[
    {
  "id": 1,
  "country": " Afghanistan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.emro.who.int/afg/afghanistan-news/afghanistans-new-national-health-policy-20252030-a-roadmap-to-a-healthier-future.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://polioeradication.org/news/technical-advisory-group-urges-strong-action-to-eradicate-polio-in-afghanistan/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://extranet.who.int/countryplanningcycles/sites/default/files/planning_cycle_repository/afghanistan/afghanistan_cmyp_2006-2010.pdf ",
        "https://polioeradication.org/wp-content/uploads/2020/07/Afghanistan-TAG-Report-20200630.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.adb.org/sites/default/files/linked-documents/55012-001-sd-03.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10409276/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 2,
  "country": " Albania",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1464370/pdf ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC5480270/",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC5853421/",
        "https://curatiofoundation.org/final-evaluation-of-gavis-support-to-albania/",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://napglobalnetwork.org/wp-content/uploads/2023/11/napgn-en-2023-albania-nap-progress-report.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.sabin.org/app/uploads/2023/06/Exploring-Determinants-of-Response-Readiness-among-MICs_Final-Report_June-9-2023.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/news-room/13-10-2023-albania--a-new-study-offers-further-proof-that-the-covid-19-vaccine-booster-is-vital-for-health-workers ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 3,
  "country": "Algeria",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/88420c69c4147738eb544478c16d445cdffad9cf_1.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.perplexity.ai/search/are-there-clearly-defined-resp-9tMj67KvQVyQQO6EcjT95w ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "2"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    }
  ]
}, {
  "id": 4,
  "country": "Andorra",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "1"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "1"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "1"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://ycharts.com/indicators/andorra_coronavirus_full_vaccination_rate ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "1"
    }
  ]
}, {
  "id": 5,
  "country": "Angola",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2025-03/WHO%20Angola%20Annual%20Report%202024.pdf ",
        "https://angola.un.org/pt/278769-angola-receives-vaccines-fight-cervical-cancer ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/875631624974382471/Project-Information-Document-Angola-COVID-19-Strategic-Preparedness-And-Response-Project-P176630.docx",
        "https://documents1.worldbank.org/curated/en/825051627869639144/pdf/Angola-COVID-19-Strategic-Preparedness-and-Response-Project.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://1325naps.peacewomen.org/index.php/angola/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.eib.org/en/press/news/angola-receives-vaccines-to-fight-cervical-cancer",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/media/152216/file/Angola-2023-COAR.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 6,
  "country": "Antigua and Barbuda",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.paho.org/en/news/27-4-2023-countries-caribbean-agree-strengthen-national-immunization-programs-through ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/caribbean-immunization-technical-advisory-group-citag-first-nitag-its-kind",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.paho.org/en/news/19-8-2024-antigua-and-barbuda-and-st-kitts-and-nevis-leading-global-vaccination-rates",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/caribbean-immunization-technical-advisory-group-citag-first-nitag-its-kind",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10850980/",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.paho.org/fr/node/96754 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-atg.pdf?sfvrsn=83b3e061_3&download=true ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 7,
  "country": "Argentina",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "http://www.worldbank.org/en/results/2025/02/04/-strengthening-argentina-s-health-response-capacity-during-the-covid-19-pandemic-and-beyond ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10783979/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.worldbank.org/en/results/2025/02/04/-strengthening-argentina-s-health-response-capacity-during-the-covid-19-pandemic-and-beyond",
        "https://www.unicef.org/media/140051/file/Argentina-case-study-Building-confidence-in-routine-childhood-vaccines-2023.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11265310/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/media/140051/file/Argentina-case-study-Building-confidence-in-routine-childhood-vaccines-2023.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://ycharts.com/indicators/argentina_coronavirus_vaccination_rate_any_dosage ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 8,
  "country": "Armenia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/news-room/photo-stories/item/armenia-launches-revised-immunization-schedule-and-catch-up-campaign ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/410df9cded98239903d7ed30a75f52574696c43b_1.pdf ",
        "https://www.vaccines4life.com/wp-content/uploads/2021/05/NITAGs-Technical-Report-Updated-FINAL.June_.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://immunizationeconomics.org/wp-content/uploads/2017/12/BRIEF19.pdf",
        "https://pivipartners.org/armenia/",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pivipartners.org/armenia/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://hetq.am/en/article/169266 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 9,
  "country": "Australia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://researchaustralia.org/wp-content/uploads/2024/06/WEB-Responses-to-survey-questions-NIP-13-June-2024.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www1.racgp.org.au/newsgp/professional/new-laws-make-vaccination-reporting-mandatory",
        "https://consultations.health.gov.au/ohp-immunisation-branch/discussion-paper-towards-the-national-immunisation/supporting_documents/Consultation%20Paper%20on%20Australias%20National%20Immunisation%20Strategy%202025%20to%202030.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://journals.sagepub.com/doi/full/10.1177/09685332211002594",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.health.gov.au/news/new-campaign-reminds-parents-and-carers-about-the-importance-of-timely-childhood-vaccination ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://ncirs.org.au/sites/default/files/2024-10/NCIRS%20Annual%20Immunisation%20Coverage%20Report%202023.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 10,
  "country": "Austria",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No ",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8706289/ ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10604541/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://ycharts.com/indicators/austria_coronavirus_full_vaccination_rate ",
        "https://tradingeconomics.com/austria/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    }
  ]
}, {
  "id": 11,
  "country": "Azerbaijan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://azerbaijan.un.org/en/173315-azerbaijan-aims-reach-70-coverage-covid-19-vaccines-mid-2022-after-having-exceeded-global",
        "https://www.who.int/europe/news/item/30-05-2024-boosting-vaccine-storage--transportation--handling--and-management-in-azerbaijan",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9111775/",
        "https://azerbaijan.un.org/en/249964-eu-and-who-boost-their-commitment-enhance-vaccine-safety-azerbaijan",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://rm.coe.int/eng-coe-azerbaijan-strategy-and-action-plan-on-execution-15-02-2024/1680aee02f ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.opengovpartnership.org/wp-content/uploads/2017/05/Azerbaijan_OGP-full-report_May2017.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.ceicdata.com/en/azerbaijan/social-health-statistics/az-immunization-measles--of-children-aged-1223-months ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 12,
  "country": "Bahamas",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.tribune242.com/news/2025/feb/12/health-officials-note-vaccine-rates-fall-short-of-pre-pandemic-levels/",
        "https://tradingeconomics.com/bahamas/immunization-measles-percent-of-children-ages-12-23-months-wb-data.html",
        "",
        "",
        "1"
      ],
      "totalScore": "3"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2023-07/tor-template-eng-final_web.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.paho.org/en/stories/bahamas-protecting-population-safe-and-effective-medicines-and-vaccines",
        "https://opm.gov.bs/remarks-bahamas-receives-first-batch-of-covid-19-vaccines-through-covax-facility/",
        "https://opm.gov.bs/vaccine/covid-19-vaccines-faqs/",
        "",
        "1"
      ],
      "totalScore": "3"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    }
  ]
}, {
  "id": 13,
  "country": "Bahrain",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/9a8a000924df684744ca9c9868aff060d66058d5_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.moh.gov.bh/Content/Upload/File/637933076434107917-WHOEMBAH001E-eng.pdf",
        "http://www.health.gov.bh/HealthInfo/AEFI?lang=en",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.moh.gov.bh/GenomeProject/AwarenessCampaigns?lang=en ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/bahrain/coronavirus-vaccination-total ",
        "https://tradingeconomics.com/bahrain/immunization-pol3-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 14,
  "country": "Bangladesh",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8687081/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10310053/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://chrfbd.org/blogs/2b26630f-a96d-4f02-b853-5129638eb3ed ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://communityengagementhub.org/wp-content/uploads/sites/2/2021/10/CEA-during-the-COVID-19-pandemic-Bangladesh.pdf",
        "https://journals.plos.org/globalpublichealth/article?id=10.1371%2Fjournal.pgph.0004178",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://chrfbd.org/blogs/2b26630f-a96d-4f02-b853-5129638eb3ed ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://journals.plos.org/globalpublichealth/article?id=10.1371%2Fjournal.pgph.0004178 ",
        "https://data.unicef.org/wp-content/uploads/cp/immunisation/bgd.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 15,
  "country": "Barbados",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8643144/",
        "https://easterncaribbean.un.org/en/126914-barbados-receives-its-second-batch-covid-19-vaccines-through-covax-facility",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://energy.gov.bb/wp-content/uploads/2024/09/Implementation-Plan-BNEP.pdf ",
        "https://www.iccp-portal.org/system/files/plans/brb_B3_s21_NCD%20Strategic%20Plan%202020-2025.pdf ",
        "https://commonseas.com/uploads/Publications-Masonry/071524_Barbados_NAP_FINAL-compressed.pdf ",
        "https://commonseas.com/news/new-barbados-national-action-plan ",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.health.gov.bb/News/Press-Releases/Campaign-To-Increase-Uptake-Of-Chi ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://barbadostoday.bb/2024/09/14/promising-improvement-in-vaccination-rates-health-ministry-says/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 16,
  "country": "Belarus",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://prddsgofilestorage.blob.core.windows.net/api/country-plan-pdf/2023-01-17-00-00-18/public-plan-627020.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://eeca.unfpa.org/en/news/signs-progress-fight-against-cervical-cancer-across-eastern-europe-and-central-asia-region",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/ ",
        "https://www.nitag-resource.org/sites/default/files/2023-07/tor-template-eng-final_web.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/ ",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1464370/full ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/belarus/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 17,
  "country": "Belgium",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.inovigate.com/media/filer_public/b8/df/b8df7b0b-80e3-4384-8dd3-14afd49037fe/vaccine_landscape_report_22-09-20_final.pdf",
        "https://vlaamsapothekersnetwerk.be/sites/default/files/2021-12/Belgian%20vaccines%20landscape%20analysis%20(Inovigate,%202020).pdf",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6278871/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "no source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://journals.sagepub.com/doi/full/10.1177/09685332211002594 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://jech.bmj.com/content/jech/early/2023/12/26/jech-2023-220751.full.pdf ",
        "https://www.healthybelgium.be/en/health-status/communicable-diseases/vaccine-preventable-diseases ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 18,
  "country": "Belize",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/099030724003033897/pdf/P177987106d3c301f191c81a89f3e00ea31.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "no souce",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11622853/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10483062/ ",
        "https://www.paho.org/en/news/3-11-2023-belize-emerges-winner-caribbean-immunization-surveillance-award ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 19,
  "country": "Benin",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/88420c69c4147738eb544478c16d445cdffad9cf_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9203714/",
        "https://extranet.who.int/countryplanningcycles/sites/default/files/country_docs/Benin/benin_cmyp_draft_3_du_07_05_13_-_en.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/88420c69c4147738eb544478c16d445cdffad9cf_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/46bb8c6ff2efadd38335fe2481d2a9037fbc9520_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11841864/ ",
        "https://tradingeconomics.com/benin/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 20,
  "country": "Bhutan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.adb.org/sites/default/files/linked-documents/55083-001-ld-09.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://extranet.who.int/sph/sites/default/files/document-library/document/IAR%20COVID-19%20Bhutan%20(04-05%20May%202021).pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "http://www.bhutantoday.bt/%F0%9D%90%8E%F0%9D%90%8F%F0%9D%90%88%F0%9D%90%8D%F0%9D%90%88%F0%9D%90%8E%F0%9D%90%8D-%F0%9D%90%8F%F0%9D%90%AB%F0%9D%90%A8%F0%9D%90%A3%F0%9D%90%9E%F0%9D%90%9C%F0%9D%90%AD-%F0%9D%90%85%F0%9D%90%9A/ ",
        "https://www.bhutanaudit.gov.bt/wp-content/uploads/2022/03/Strategic-Plan-2020-2025.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8136800/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.elgaronline.com/downloadpdf/edcollchap-oa/book/9781803929170/book-part-9781803929170-25.pdf ",
        "https://stacks.cdc.gov/view/cdc/175425/cdc_175425_DS1.pdf",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 21,
  "country": "Bolivia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gavi.org/country-documents/bolivia",
        "https://www.gavi.org/news/media-room/bolivias-successful-rotavirus-vaccine-initiative",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2023-07/tor-template-eng-final_web.pdf ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11265310/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11265310/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://scielosp.org/pdf/rpsp/2024.v48/e63/en ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9997729/ ",
        "https://tradingeconomics.com/bolivia/immunization-pol3-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 22,
  "country": "Bosnia and Herzegovina",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/cb05e048b8dabcea655590e26dc77daf90e06c02_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pubmed.ncbi.nlm.nih.gov/37457274/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2023/periodic-intensification-of-routine-immunization-activities-increase-vaccination-in-bosnia-and-herzegovina ",
        "https://tradingeconomics.com/bosnia-and-herzegovina/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 23,
  "country": "Botswana",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.afro.who.int/news/botswana-sets-sights-enhanced-health-outcomes-development-new-immunization-strategy",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/news/botswana-sets-sights-enhanced-health-outcomes-development-new-immunization-strategy",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/news/botswana-sets-sights-enhanced-health-outcomes-development-new-immunization-strategy",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://napglobalnetwork.org/wp-content/uploads/2020/06/napgn-en-2020-nap-framework-for-botswana.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://covid19communicationnetwork.org/wp-content/uploads/2023/11/Botswana_Success_Story_published-june-9th.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://covid19communicationnetwork.org/wp-content/uploads/2023/11/Botswana_Success_Story_published-june-9th.pdf ",
        "https://tradingeconomics.com/botswana/immunization-hepb3-percent-of-one-year-old-children-wb-data.html",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 24,
  "country": "Brazil",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.scielo.br/j/ress/a/ztJ5qTnd8Fz6Q9vPyK6XYCr/?lang=en",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://braziliannr.com/2024/06/09/brazil-celebrates-two-years-without-measles-cases/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/cb05e048b8dabcea655590e26dc77daf90e06c02_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.scielo.br/j/rsp/a/CS5YRcMc3z4Cq4QtSBDLXXG/",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8233032/",
        "https://www.scielo.br/j/ress/a/HQCTJkYr9L8T3mTRZVjdTBD/?format=pdf&lang=en",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/cb05e048b8dabcea655590e26dc77daf90e06c02_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10911277/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.medscape.com/viewarticle/brazil-bucked-trend-childhood-vaccination-2023-2024a1000dg5",
        "https://www.scielo.br/j/rsbmt/a/GgWf39St5zpmFXQmxGpcnqs/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 25,
  "country": "Brunei",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://measlesrubellapartnership.org/brunei-darussalam-cambodia-japan-verified-as-achieving-measles-elimination-western-pacific-region-achieves-progress-towards-measles-elimination-but-challenges-remain/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9716409/",
        "https://journals.hh-publisher.com/index.php/pmmb/article/download/701/397/4414",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://moh.gov.bn/wp-content/uploads/2024/10/BRUMAP-NCD-2021_compressed.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-brn.pdf?sfvrsn=b2cb4943_3&download=true ",
        "https://tradingeconomics.com/brunei/coronavirus-vaccination-rate ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 26,
  "country": "Bulgaria",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1464370/full ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1464370/full ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.asset-scienceinsociety.eu/outputs/best-practice-platform/vaksinko-informational-campaign-about-vaccines-bulgaria ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://ycharts.com/indicators/bulgaria_coronavirus_full_vaccination_rate ",
        "https://en.wikipedia.org/wiki/COVID-19_vaccination_in_Bulgaria ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 27,
  "country": "Burkina Faso",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.ghspjournal.org/content/11/5/e2300044",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/news/media-room/burkina-faso-taking-on-typhoid",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/88420c69c4147738eb544478c16d445cdffad9cf_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10615239/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.actntdswest.org/sites/default/files/inline-files/Burkina%20Faso-FY25%20work%20plan.pdf",
        "https://www.fondation-merieux.org/wp-content/uploads/2023/06/introducing-pcv-rotavirus-vaccine-2023-day-2-joseph-biey.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/burkina-faso-taking-on-typhoid ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-bfa.pdf?sfvrsn=52920509_3&download=true ",
        "https://www.gavi.org/vaccineswork/burkina-faso-taking-on-typhoid ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 28,
  "country": "Burundi",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gavi.org/news/media-room/burundi-introduces-malaria-vaccine-routine-immunization",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/news/media-room/burundi-introduces-malaria-vaccine-routine-immunization",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "3"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.gavi.org/programmes-impact/country-hub/africa/burundi ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    }
  ]
}, {
  "id": 29,
  "country": "Cabo Verde",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://insp.gov.cv/wp-content/uploads/2024/02/Knowledge-attitudes-and-adherence-of-the-Cape-Verdean-population-to-the-COVID-19-vaccine.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "2"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://insp.gov.cv/wp-content/uploads/2024/02/Knowledge-attitudes-and-adherence-of-the-Cape-Verdean-population-to-the-COVID-19-vaccine.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    }
  ]
}, {
  "id": 30,
  "country": "Cambodia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.ungm.org/Public/Notice/129360",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "http://cdc-crdb.gov.kh/en/twg-jmi/sector_strategy/NIPSP_2016_2020.pdf",
        "https://www.adb.org/sites/default/files/linked-documents/55104-001-ld-01.pdf",
        "https://www.adb.org/sites/default/files/linked-documents/55104-001-ld-05.pdf",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.wvi.org/publications/newsletter/cambodia/cambodia-implementation-social-accountability-framework-i-saf",
        "https://www.rrh.org.au/journal/article/263/",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.linkedin.com/pulse/building-capacity-health-system-unicef-cambodias-george-laryea-adjei-cxjqc ",
        "https://www.developmentaid.org/news-stream/post/187124/cambodia-measles-rubella-vaccination ",
        "https://www.clintonhealthaccess.org/news/cambodia-launches-national-measles-rubella-vaccination-campaign-to-protect-over-1-5-million-children/ ",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://ycharts.com/indicators/cambodia_coronavirus_full_vaccination_rate ",
        "https://www.afro.who.int/sites/default/files/2023-08/Cabo%20Verde.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 31,
  "country": "Cameroon",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.afro.who.int/countries/cameroon/news/child-health-improves-cameroon-one-year-after-malaria-vaccine-introduction",
        "https://www.unicef.org/wca/media/10481/file/Cameroon-RTM-Case-Study.pdf.pdf",
        "https://www.gavi.org/vaccineswork/cameroon-maps-out-strategy-reach-zero-dose-children-immunisation",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/cameroons-historic-malaria-vaccine-introduction-shows-signs-success-one-year",
        "https://www.gavi.org/vaccineswork/Half-century-EPI-Cameroon-Dr-Tchokfe-Shalom-Ndoula",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.fondation-merieux.org/wp-content/uploads/2023/06/introducing-pcv-rotavirus-vaccine-2023-day-2-joseph-biey.pdf ",
        "https://www.nitag-resource.org/sites/default/files/a1c99f72632c89622c12a89dc8355b6839099850_1.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.cmi.no/publications/file/4977-implementing-a-transparency-and-accountability.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/wca/media/10481/file/Cameroon-RTM-Case-Study.pdf.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/wca/media/10481/file/Cameroon-RTM-Case-Study.pdf.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-cmr.pdf?sfvrsn=fb0d6c18_3&download=true ",
        "https://tradingeconomics.com/cameroon/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "https://reliefweb.int/report/cameroon/factors-associated-full-vaccination-and-zero-vaccine-dose-children-aged-12-59-months-6-health-districts-cameroon ",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 32,
  "country": "Canada",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.canada.ca/en/public-health/services/immunization-vaccine-priorities/national-immunization-strategy.html",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://science.gc.ca/site/science/en/blogs/science-health/vaccines-canada-why-meeting-our-routine-vaccination-goals-matters",
        "https://www.canada.ca/en/public-health/services/immunization-vaccine-priorities/national-immunization-strategy/vaccination-coverage-goals-vaccine-preventable-diseases-reduction-targets-2025.html",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.vaccines4life.com/wp-content/uploads/2021/05/NITAGs-Technical-Report-Updated-FINAL.June_.pdf",
        "https://journals.sagepub.com/doi/full/10.1177/09685332211002594 ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://ca.gsk.com/media/6981/adult-vaccines-access-report.pdf",
        "https://covid19tracker.ca/vaccinationtracker.html",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6284504/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/news/naci-mandate-expands-support-local-decision-making-vaccine-programs ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.canada.ca/en/public-health/services/immunization-vaccines/vaccination-coverage/childhood-seasonal-immunization-coverage-survey-2024-results.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 33,
  "country": "Central African Republic",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gavi.org/news/media-room/gavi-increases-support-reach-all-children-immunisation-central-african-republic",
        "https://www.gavi.org/news/media-room/central-african-republic-introduces-new-malaria-vaccine-routine-epi-vaccinate-around-200000-children-2024",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/central-african-republic/gavi-increases-support-reach-all-children-immunisation-central-african-republic ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "3"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/car/media/2026/file/UNICEF%20CAR%20%7C%20Annual%20report%202023.pdf.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    }
  ]
}, {
  "id": 34,
  "country": "Chad",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gavi.org/vaccineswork/chad-launches-pneumococcal-vaccine-historic-multi-vaccine-rollout",
        "https://reliefweb.int/report/chad/chad-launches-vaccination-against-malaria-pneumococcal-disease-and-rotavirus-diarrhea",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/chad/chad-launches-vaccination-against-malaria-pneumococcal-disease-and-rotavirus",
        "https://www.gavi.org/news/media-room/chad-launches-vaccination-against-malaria-pneumococcal-disease-and-rotavirus",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/despite-pandemic-chad-improving-routine-vaccination-coverage",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6284504/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/media/152981/file/Chad-2023-COAR.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 35,
  "country": "Chile",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/e777e4bbe47bded147e7eacf884ed034a8412506_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "No source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/e777e4bbe47bded147e7eacf884ed034a8412506_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/e777e4bbe47bded147e7eacf884ed034a8412506_1.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/chile/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "https://tradingeconomics.com/chile/coronavirus-vaccination-rate ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11898036/ ",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 36,
  "country": "China",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1492873/full",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/brand-new-way-training-nitag-exemple-china ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8428415/",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "No source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8428415/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10720319/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9234389/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 37,
  "country": "Colombia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://scielosp.org/article/rpsp/2024.v48/e63/ ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11265310/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11265310/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.bbc.com/news/world-latin-america-57819261 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.ssph-journal.org/journals/international-journal-of-public-health/articles/10.3389/ijph.2024.1606689/full ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 38,
  "country": "Comoros",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/953921625726841435/pdf/Comoros-Support-to-COVID-19-Vaccine-Purchase-and-Health-System-Strengthening-Project.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/953921625726841435/pdf/Comoros-Support-to-COVID-19-Vaccine-Purchase-and-Health-System-Strengthening-Project.pdf",
        "https://www.unicef.org/media/116231/file/Comoros-2021-COAR.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/953921625726841435/pdf/Comoros-Support-to-COVID-19-Vaccine-Purchase-and-Health-System-Strengthening-Project.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1470021/full ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 39,
  "country": "Congo (Congo-Brazzaville)",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://terrance.who.int/mediacentre/data/sage/SAGE_Docs_Ppt_April2019/1_session_report_from_ivb_director/April2019_Session1_Meeting_Report_Regional_ITAG.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "2"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-cog.pdf?sfvrsn=5ae416e5_3&download=true ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    }
  ]
}, {
  "id": 40,
  "country": "Costa Rica",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://quatro.legal/vaccination-in-costa-rica-legislation-duties-and-prerogatives/ ",
        "https://www.nitag-resource.org/news/costa-rica-introduces-two-new-vaccines-national-immunization-program ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://quatro.legal/vaccination-in-costa-rica-legislation-duties-and-prerogatives/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://1325naps.peacewomen.org/index.php/croatia/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://ticotimes.net/2024/09/06/costa-rica-begins-vaccination-campaign-to-fight-respiratory-illnesses ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-cri.pdf?sfvrsn=df1a5ae6_3&download=true ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 41,
  "country": "Croatia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2023-07/tor-template-eng-final_web.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.expatincroatia.com/vaccinations/",
        "https://intapi.sciendo.com/pdf/10.2478/acph-2023-0029",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://1325naps.peacewomen.org/index.php/croatia/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.opengovpartnership.org/wp-content/uploads/2019/02/Croatia_Action-Plan_2018-2020_EN.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10657860/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 42,
  "country": "Cuba",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://dukeghic.org/2021/09/11/will-cubas-home-grown-vaccine-strategy-pay-off/",
        "https://en.granma.cu/cuba/2025-02-18/vaccination-against-human-papillomavirus-to-be-carried-out-for-the-first-time-in-cuba",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pubmed.ncbi.nlm.nih.gov/9796389/",
        "https://en.cibercuba.com/noticias/2025-02-18-u1-e208933-s27061-nid297365-aplicaran-primera-vez-cuba-vacuna-contra-papiloma",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pubmed.ncbi.nlm.nih.gov/33780421/",
        "http://mediccreview.org/vaccine-related-adverse-events-in-cuban-children-1999-2008/",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://extranet.who.int/countryplanningcycles/sites/default/files/country_docs/Cuba/cuba_cmyp_2007-2011.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.cmedlabsfoundation.com/updates-emerging-issues/cuba-leads-the-world-in-vaccinating-children-as-young-as-two-against-covid/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 43,
  "country": "Cyprus",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "no source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC7393851/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.pio.gov.cy/en/campaigns/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10012892/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 44,
  "country": "Czechia (Czech Republic)",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.cz/wp-content/uploads/2025/02/CCS-Czechia.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://brill.com/view/journals/ejhl/28/3/article-p323_7.xml?language=en",
        "https://rozalio.cz/english/",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1464370/full",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11513313/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 45,
  "country": "Democratic Republic of the Congo",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.path.org/our-impact/media-center/drc-makes-historic-gains-child-immunization-coverage/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/drc-2nd-country-central-africa-establish-nitag ",
        "https://publications.jsi.com/JSIInternet/Inc/Common/_download_pub.cfm?id=10280&lid=3 ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://gh.bmj.com/content/9/10/e015675",
        "https://www.path.org/our-impact/media-center/drc-makes-historic-gains-child-immunization-coverage/",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://1325naps.peacewomen.org/index.php/democratic-republic-of-the-congo-drc/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/media/167386/file/DR-Congo-Humanitarian-SitRep-No.-5-(Level-3-Mpox),-31-December-2024.pdf.pdf ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9746480/ ",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/media/152761/file/Democratic-Republic-of-the-Congo-2023-COAR.pdf ",
        "https://www.path.org/our-impact/media-center/drc-makes-historic-gains-child-immunization-coverage/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 46,
  "country": "Denmark",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://um.dk/-/media/websites/umdk/danish-site/danida/partnerskaber/internationale-organisationer/gavi-organisation-strategy-final-1.ashx ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.vaccines4life.com/wp-content/uploads/2021/05/NITAGs-Technical-Report-Updated-FINAL.June_.pdf ",
        "https://www.nitag-resource.org/sites/default/files/2023-07/tor-template-eng-final_web.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.sst.dk/-/media/English/Publications/2021/Corona/Vaccination/The-Danish-Vaccination-Programme-Against-COVID-19.ashx?la=en&hash=C5AC701C8D17412ABA3B1871CF2BF2B90B1353E4",
        "https://mibaen.ssi.dk/surveillance-systems/automatic-vaccination-surveillance",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.vaccines4life.com/wp-content/uploads/2021/05/SAAV_Environmental-Scan_Denmark.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://overcomingobstaclestovaccination.eu/en/solutions/onsite-visits/onsite-visit-copenhagen-denmark ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.sst.dk/en/english/publications/2024/The-Danish-childhood-vaccination-programme-2023",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11004589/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 47,
  "country": "Djibouti",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://extranet.who.int/countryplanningcycles/sites/default/files/country_docs/Djibouti/300511_djibouti_cmyp.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/fr/actualites/librarie-de-documents/proposal-nvs-ipv-djibouti-francais-0 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-dji.pdf?sfvrsn=1808fe8c_3&download=true ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://ijariie.com/AdminUploadPdf/Advancements_in_Disease_Surveillance_and_Data_Coverage_in_Djibouti__A_Commentary_and_Brief_Overview_ijariie23162.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 48,
  "country": "Dominica",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2020-06/FIELDGUIDE-NITAG-JUNE8.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9847406/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/caribbean-immunization-technical-advisory-group-citag-first-nitag-its-kind ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.paho.org/en/news/3-5-2023-vaccination-week-americas-2023-observed-dominica",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 49,
  "country": "Dominican Republic",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://dominicantoday.com/dr/health/2024/09/25/dominican-republic-commits-to-achieving-universal-health-coverage-by-2030/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.exemplars.health/emerging-topics/ecr/dominican-republic/how-did-the-dominican-republic-respond",
        "https://data.unicef.org/wp-content/uploads/cp/immunisation/dom.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "3"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://en.ssi.dk/news/epi-news/2024/no-10---2024 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    }
  ]
}, {
  "id": 50,
  "country": "Ecuador",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.paho.org/en/news/18-12-2024-note-third-regional-national-immunization-technical-advisory-group-nitag-network",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://iris.paho.org/handle/10665.2/60612 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pubmed.ncbi.nlm.nih.gov/39687254/",
        "https://journal.paho.org/en/articles/experiences-and-challenges-ecuadorean-national-advisory-commission-serious-events",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11265310/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.paho.org/en/news/18-12-2024-note-third-regional-national-immunization-technical-advisory-group-nitag-network ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://ycharts.com/indicators/ecuador_coronavirus_vaccination_rate_any_dosage ",
        "https://tradingeconomics.com/ecuador/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.paho.org/sites/default/files/2025-02/2025-feb-14-phe-risk-assessment-yellow-fever-final2.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 51,
  "country": "Egypt",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://english.ahram.org.eg/News/536386.aspx",
        "https://www.zawya.com/en/business/healthcare/egypt-unveils-strategy-to-localize-vaccine-production-expand-exports-qaq4tyj3",
        "https://icomgroup.org/evma/",
        "https://evma-egypt.org/wp-content/uploads/2024/12/Strategy-Combined-.pdf",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.emro.who.int/emhj-volume-29-2023/volume-29-issue-9/fourth-meeting-of-the-regional-verification-commission-on-measles-and-rubella-elimination-in-the-eastern-mediterranean-region1.html",
        "https://hivpreventioncoalition.unaids.org/sites/default/files/attachments/egypt_hiv_nsp_2021-2025_final.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10850980/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.emro.who.int/egy/programmes/expanded-programme-on-immunization.html",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.fondation-merieux.org/wp-content/uploads/2023/06/introducing-pcv-rotavirus-vaccine-2023-day-2-joseph-biey.pdf ",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1464370/full",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://fount.aucegypt.edu/studenttxt/101/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-egy.pdf?sfvrsn=643481a7_3&download=true ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 52,
  "country": "El Salvador",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.unicef.org/stories/reaching-every-child-vaccination-el-salvador",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11265310/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/359951618884067584/pdf/El-Salvador-COVID-19-Emergency-Response-Project-Restructuring-and-Additional-Financing.pdf",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9179345/",
        "https://www.who.int/emergencies/funding/health-emergency-appeals/2022/2023/2023-appeals/appeal-el-salvador",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11265310/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/emergencies/funding/health-emergency-appeals/2022/2023/2023-appeals/appeal-el-salvador ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-slv.pdf?sfvrsn=febf6647_3&download=true ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 53,
  "country": "Equatorial Guinea",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "1"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "1"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "1"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-gnq.pdf?sfvrsn=fe581699_3&download=true ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "1"
    }
  ]
}, {
  "id": 54,
  "country": "Eritrea",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://extranet.who.int/countryplanningcycles/sites/default/files/planning_cycle_repository/eritrea/eritrea_cmyp_doc.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2023/improving-access-to-immunization-in-hard-to-reach-areas-of-eritrea",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/esa/stories/eritrea-maintains-over-95-cent-coverage-nationwide-immunization-programmes ",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2023/improving-access-to-immunization-in-hard-to-reach-areas-of-eritrea ",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2023/improving-access-to-immunization-in-hard-to-reach-areas-of-eritrea ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 55,
  "country": "Estonia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.oecd.org/content/dam/oecd/en/publications/reports/2023/06/health-system-performance-assessment-framework-for-estonia_0ed8bd81/e67df802-en.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1464370/full ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10604541/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://fra.europa.eu/sites/default/files/fra_uploads/ee_report_on_national_vaccine_deployment.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://data.unicef.org/wp-content/uploads/2022/07/est.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 56,
  "country": "Eswatini",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gavi.org/vaccineswork/eswatini-burdened-doubly-hiv-and-cervical-cancer-targets-safety-next-generation",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/eswatini-burdened-doubly-hiv-and-cervical-cancer-targets-safety-next-generation",
        "https://www.afro.who.int/sites/default/files/2022-10/2207-154%20WHO%20Eswatini%20Country%20Office%20Biennual%20Report%202020-2021.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/countries/eswatini/news/eswatini-health-workers-trained-adverse-events-following-immunization-surveillance",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://icap-aws-bucket.s3.amazonaws.com/icapcolumbiau/wp-content/uploads/pages-ICAP-Eswatini_Report-002.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10460101/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 57,
  "country": "Ethiopia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC7171468/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC7171468/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/ethiopia-establishes-its-nitag ",
        "https://www.nitag-resource.org/sites/default/files/3d219f294dd1f097ed01caf3bb0c883ec15be8cd_1.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10948120/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/ethiopia-establishes-its-nitag",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/news/ethiopia-establishes-its-nitag",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11717282/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 58,
  "country": "Fiji",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/westernpacific/newsroom/feature-stories/item/going-the-extra-mile-to-deliver-vaccines-in-fiji",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/westernpacific/newsroom/feature-stories/item/going-the-extra-mile-to-deliver-vaccines-in-fiji",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://fijiredcross.org/wp-content/uploads/2022/06/IFRC-Community-Feedback-Update-Fiji-COVID-19-Response-Final-WEB.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.greenpolicyplatform.org/sites/default/files/downloads/policy-database/Fiji%20NDC%20Implementation%20Roadmap%202017-2030.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.ivi.int/fiji-launches-mass-vaccination-campaign-against-typhoid-in-the-northern-division/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/fiji/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 59,
  "country": "Finland",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://thl.fi/en/topics/infectious-diseases-and-vaccinations/information-about-vaccinations/finnish-national-vaccination-programme",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://thl.fi/en/topics/infectious-diseases-and-vaccinations/information-about-vaccinations/finnish-national-vaccination-programme",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://thl.fi/en/-/the-vaccination-coverage-of-young-children-in-finland-is-very-good-the-proportion-of-unvaccinated-children-among-those-born-in-2021-is-slightly-higher-than-in-the-previous-age-groups ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://thl.fi/en/topics/infectious-diseases-and-vaccinations/information-about-vaccinations/vaccination-programme-for-children-and-adults ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 60,
  "country": "France",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/resources/french-technical-vaccination-committee-ctv ",
        "https://www.has-sante.fr/jcms/c_2758065/en/technical-committee-for-vaccinations ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8061787/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/resources/french-technical-vaccination-committee-ctv",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/resources/french-technical-vaccination-committee-ctv ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.statista.com/statistics/1202549/vaccination-number-covid19-france/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10843936/ ",
        "https://academic.oup.com/eurpub/article/34/1/170/7462254?login=false ",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 61,
  "country": "Gabon",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.unicef.org/gabon/en/topics/immunization",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/551171635172379620/pdf/Gabon-COVID-19-Strategic-Preparedness-and-Response-Project-Additional-Financing.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/551171635172379620/pdf/Gabon-COVID-19-Strategic-Preparedness-and-Response-Project-Additional-Financing.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/551171635172379620/pdf/Gabon-COVID-19-Strategic-Preparedness-and-Response-Project-Additional-Financing.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-gab.pdf?sfvrsn=e4974919_3&download=true ",
        "https://data.unicef.org/wp-content/uploads/cp/immunisation/gab.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 62,
  "country": "Gambia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://extranet.who.int/countryplanningcycles/sites/default/files/planning_cycle_repository/gambia/comprehensive_multi_year_plan.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://gambia.un.org/en/109407-launch-gambia%E2%80%99s-national-immunization-technical-advisory-group-gambia-gambia-nitag ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://extranet.who.int/sph/file/6284/download?token=QNOUaPxM",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/ghana-inaugurates-nitag",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://gambia.un.org/en/109407-launch-gambia%E2%80%99s-national-immunization-technical-advisory-group-gambia-gambia-nitag",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10361478/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10361478/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 63,
  "country": "Georgia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.linkedimmunisation.org/wp-content/uploads/2021/10/Georgia-Transition-Case-Study-final.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://idfi.ge/en/vaccination-process-in-georgia",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.grits.state.ga.us/docs/8_Accountability_Policy_06012016.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.fondation-merieux.org/wp-content/uploads/2023/06/introducing-pcv-rotavirus-vaccine-2023-day-2-joseph-biey.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.linkedimmunisation.org/wp-content/uploads/2021/10/Georgia-Transition-Case-Study-final.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://sjr-redesign.stjude.org/content/dam/research-redesign/centers-initiatives/hpv-cancer-prevention-program/se-roundtable/state-profiles/georgia-state-data-2024.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://dph.georgia.gov/vpd-data ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 64,
  "country": "Germany",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.vaccines4life.com/wp-content/uploads/2021/05/NITAGs-Technical-Report-Updated-FINAL.June_.pdf ",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.leopoldina.org/en/topics/vaccinations/vaccine-development-and-recommendations/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.fondation-merieux.org/wp-content/uploads/2023/06/introducing-pcv-rotavirus-vaccine-2023-day-2-joseph-biey.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.rki.de/DE/Themen/Infektionskrankheiten/Impfen/Eliminationsprogramme/Nationale-Verifizierungskommission-Masern-Roeteln/Berichte/Bericht_2023_en.pdf?__blob=publicationFile&v=2 ",
        "https://www.reportlinker.com/dataset/df5ed0a1282da5c4c3418421688bcabe9c3473b5 ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11488180/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 65,
  "country": "Ghana",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.advocacyincubator.org/news/2024-03-19-csos-in-ghana-gather-in-support-of-immunization-financing",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/news/ghana-launches-new-vaccination-campaign-against-yellow-fever",
        "https://www.gavi.org/vaccineswork/ghana-strengthens-immunization-programme",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.moh.gov.gh/wp-content/uploads/2024/10/NITAG-Ghana_IP-Manual_Final_09Oct24_Shared-with-Minister.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11865776/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.moh.gov.gh/wp-content/uploads/2024/10/NITAG-Ghana_IP-Manual_Final_09Oct24_Shared-with-Minister.pdf",
        "https://www.nitag-resource.org/news/ghana-inaugurates-nitag",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.moh.gov.gh/wp-content/uploads/2024/10/NITAG-Ghana_IP-Manual_Final_09Oct24_Shared-with-Minister.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.medrxiv.org/content/10.1101/2024.12.13.24318976v1.full ",
        "https://english.news.cn/africa/20240424/a7fe2fb692f54fe4b921d236860c0efb/c.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 66,
  "country": "Greece",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9601163/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "https://www.nitag-resource.org/sites/default/files/2023-07/tor-template-eng-final_web.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11311648/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/0fb9413f5c0dee22b6319c30e22d71ab8a76f1c2_1.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/europe/activities/strengthening-national-immunization-technical-advisory-groups-(nitags)/national-immunization-technical-advisory-groups ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9914444/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://eody.gov.gr/wp-content/uploads/2024/02/pertussis-2004-2023-eng.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 67,
  "country": "Grenada",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.paho.org/en/news/27-5-2024-paho-team-conducting-comprehensive-evaluation-grenadas-national-immunization-program",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2020-06/FIELDGUIDE-NITAG-JUNE8.pdf ",
        "https://health.uct.ac.za/sites/default/files/content_migration/health_uct_ac_za/1457/files/AAVC%25202015-%2520NITAGs%2520Final.pdf",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://apps.who.int/gb/statements/WHA77/PDF/Grenada-11.4.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/caribbean-immunization-technical-advisory-group-citag-first-nitag-its-kind",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/news/caribbean-immunization-technical-advisory-group-citag-first-nitag-its-kind ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://iris.paho.org/bitstream/handle/10665.2/57281/v47e442023.pdf?sequence=1 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 68,
  "country": "Guatemala",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/about/accountability/results/who-results-report-2022-2023/country-story/2023/improving-access-to-vaccines-and-preventive-health-care-through-mobile-health-brigades-in-rural-guatemala",
        "https://media.path.org/documents/TS_opt_guatemala_rpt.pdf",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6143477/ ",
        "https://health.uct.ac.za/sites/default/files/content_migration/health_uct_ac_za/1457/files/AAVC%25202015-%2520NITAGs%2520Final.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/europe/activities/strengthening-national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10911077/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 69,
  "country": "Guinea",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gavi.org/vaccineswork/routine-immunisation-guinea-mountain-climb-find-zero-dose-children",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/routine-immunisation-guinea-mountain-climb-find-zero-dose-children",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://media.path.org/documents/TS_opt_guatemala_rpt.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/country-documents/guinea ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.gavi.org/vaccineswork/routine-immunisation-guinea-mountain-climb-find-zero-dose-children ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 70,
  "country": "Guinea-Bissau",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/guineabissau/stories/one-shot-two-vaccines-protecting-guinea-bissaus-children-through-immunization",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/658161625729285760/pdf/Guinea-Bissau-COVID-19-Vaccine-Project.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.undp.org/guinea-bissau/press-releases/undp-and-guinea-bissau-renew-partnership-strengthen-national-response-hiv-tuberculosis-and-malaria ",
        "https://www.worldbank.org/en/news/press-release/2025/01/15/world-bank-approves-20-million-dollar-project-to-strengthen-health-education-and-social-services-in-guinea-bissau ",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://bmjopen.bmj.com/content/2/6/e001509 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 71,
  "country": "Guyana",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://guyanacurrentaffairs.com/insights/vaccination-drive-2025-reaching-every-child-in-guyana/",
        "https://guyanacurrentaffairs.com/news/health-ministry-aims-for-universal-childhood-vaccination-by-2025/",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.paho.org/sites/default/files/Sne3005.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://ewsdata.rightsindevelopment.org/files/documents/59/IADB-GY-L1059_6sXfO5Q.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://guyana.un.org/en/180060-un-guyana-support-national-immunization ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://data.unicef.org/wp-content/uploads/2023/07/progress-and-challenges_wuenic2023rev_20-September.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://hpvcentre.net/statistics/reports/GUY.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 72,
  "country": "Haiti",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.paho.org/en/news/27-4-2023-vwa2023-haiti-launches-catch-campaign-les-cayes-improve-vaccination-coverage",
        "https://www.paho.org/en/news/19-7-2024-canadian-support-haiti-launches-successful-catch-diphtheria-vaccination-campaign",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/haiti-rising-vaccination-rates-despite-socio-political-unrest",
        "https://copenhagenconsensus.com/publication/haiti-priorise-immunization-rozier",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/thousands-of-haitian-children-to-be-protected-against-leading-cause-of-severe-diarrhoea ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/haiti/en/press-releases/haiti-sees-10-increase-routine-vaccination-coverage-between-2022-and-2023",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.paho.org/sites/default/files/2024-05/phsa-haiti-update-public-final_0.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 73,
  "country": "Honduras",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.unicef.org/media/152416/file/Honduras-2023-COAR.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/resources/overview-national-consultative-council-immunization-honduras ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://static1.squarespace.com/static/59bc3457ccc5c5890fe7cacd/t/667b20b15b8f632d6fb94961/1719345330024/DRIVE-Demand_factsheet_HONDURAS.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11265310/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.vaccines4life.com/wp-content/uploads/2021/05/NITAGs-Technical-Report-Updated-FINAL.June_.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.paho.org/en/news/15-7-2024-global-childhood-immunization-levels-stalled-2023-leaving-many-without-life-saving",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 74,
  "country": "Hungary",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.activecitizenship.net/multimedia/import/files/clippings-web-press-articles/Hungary_Addressing_the_Life-Course_Immunization_Approach_in_the_National_Vaccination_Policy.pdf",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9697606/",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/hungary/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11125914/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 75,
  "country": "Iceland",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/c-te-divoire/iceland-renews-commitment-global-equitable-access-vaccines-first-doses-arrive-c",
        "https://island.is/en/vaccination-overview/policy_vaccination",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.mrs.org.uk/pdf/iceland.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://data.unicef.org/wp-content/uploads/2023/07/progress-and-challenges_wuenic2023rev_20-September.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.oecd.org/content/dam/oecd/en/publications/reports/2023/12/iceland-country-health-profile-2023_e26a337c/f2868adb-en.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 76,
  "country": "India",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10747509/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/india/news/feature-stories/detail/india-vaccinates-30-million-children-against-measles-and-rubella-in-7-months",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "https://pubmed.ncbi.nlm.nih.gov/20413005/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10747509/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/news/media-room/gavi-and-government-india-establish-new-partnership-protect-millions-children-2026 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.deccanherald.com/india/16-lakh-indian-kids-missed-vital-vaccine-shots-in-2023-who-unicef-report-3105641 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 77,
  "country": "Indonesia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10602626/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "https://www.nitag-resource.org/sites/default/files/bed0e80e51e4f60f66a0e2bea384fdddc13c0da5_1.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/indonesia/procurement/request-for-proposal-rfp-117-2023.pdf?sfvrsn=c3199e9c_1",
        "https://bmjpaedsopen.bmj.com/content/8/1/e003006",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC5853604/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://dcvmn.org/wp-content/uploads/2023/11/Indonesia-Country-Profile_vf.pdf ",
        "https://immunizationeconomics.org/recent-activity/2024/11/13/sustainable-immunization-financing-in-indonesia/ ",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-idn.pdf?sfvrsn=bdb26101_3&download=true ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 78,
  "country": "Iran",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30002-4/fulltext",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pubmed.ncbi.nlm.nih.gov/20412994/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC3595652/",
        "https://www.emro.who.int/emhj-volume-28-2022/volume-28-issue-2/immunization-coverage-of-children-aged-2435-months-in-the-islamic-republic-of-iran-a-national-cluster-coverage-survey.html",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/d7bb977ed4a6c44684a566183ede58661781b3aa_2.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/d7bb977ed4a6c44684a566183ede58661781b3aa_2.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11188638/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 79,
  "country": "Iraq",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://ina.iq/eng/32576-health-minister-announces-the-success-of-the-national-measles-vaccination-campaign.html",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/news-room/feature-stories/detail/who-commends-iraq-s-world-first-in-polio-transition",
        "https://reliefweb.int/report/iraq/who-tackles-low-immunization-challenges-iraq-enar",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://reporting.unhcr.org/sites/default/files/2025-01/Iraq%20-%20Strategy%202025%20%E2%80%93%202029.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.emro.who.int/fr/iraq/news/unicef-and-who-support-national-multi-antigen-campaign-for-more-than-400-000-children.html ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://reliefweb.int/report/iraq/over-500000-children-reached-lifesaving-vaccines-ministry-health-supported-unicef-who-enarku ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://assets-eu.researchsquare.com/files/rs-5234424/v1/44964e89-3a03-41dc-8fe0-64fbaacab39c.pdf?c=1730450187 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 80,
  "country": "Ireland",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.hse.ie/eng/health/immunisation/infomaterials/niostrategy.pdf",
        "https://www.eolasmagazine.ie/achieving-equity-and-excellence-the-national-immunisation-office-strategic-plan-2024-2027/",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.hse.ie/eng/health/immunisation/infomaterials/niostrategy.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/network/map/ireland",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.hse.ie/eng/health/immunisation/infomaterials/niostrategy.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://data.unicef.org/wp-content/uploads/cp/immunisation/irl.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11241852/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 81,
  "country": "Israel",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://cris.haifa.ac.il/en/publications/the-national-immunization-technical-advisory-group-in-israel ",
        "https://www.nitag-resource.org/resources/national-immunization-technical-advisory-group-israel ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.hhrjournal.org/2022/12/06/covid-19-vaccination-in-palestine-israel-citizenship-capitalism-and-the-logic-of-elimination/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/resources/national-immunization-technical-advisory-group-israel",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/resources/national-immunization-technical-advisory-group-israel ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC7835647/ ",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6373067/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nature.com/articles/s41541-022-00526-5 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 82,
  "country": "Italy",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11540126/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11540126/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/resources/new-italian-national-immunization-technical-advisory-group-nitag-and-its-commitment ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11540126/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://annali.iss.it/index.php/anna/article/view/1505",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2023-06/ANN_23_01_04.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.statista.com/topics/10437/vaccinations-in-italy/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.oecd.org/content/dam/oecd/en/publications/reports/2023/12/italy-country-health-profile-2023_9404b600/633496ec-en.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 83,
  "country": "Ivory Coast (Côte d'Ivoire)",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gavi.org/news/media-room/gavi-and-cote-divoire-commit-successful-programmatic-and-financial-transition",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/cote-divoire/gavi-and-cote-divoire-commit-successful-programmatic-and-financial-transition",
        "https://www.aljazeera.com/news/2024/7/20/how-is-new-malaria-vaccine-drive-working-in-west-africa",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2022-09/09685332211002594.pdf ",
        "https://www.nitag-resource.org/sites/default/files/05bb82a6867d54f735105ef71d86908c5ab2d30b_1.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.aiib.org/en/projects/details/2024/_download/Cote/AIIB-PIMR_SBF_Cote-dIvoire_P000560_No.4_October_2024_Public-Version.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/05bb82a6867d54f735105ef71d86908c5ab2d30b_1.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/05bb82a6867d54f735105ef71d86908c5ab2d30b_1.pdf",
        "https://pivipartners.org/cote-divoire/ ",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2023-08/CIV.pdf",
        "https://www.gavi.org/vaccineswork/how-will-cote-d-ivoire-roll-out-malaria-vaccine ",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 84,
  "country": "Jamaica",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://jis.gov.jm/information/get-the-facts/vision-2030-jamaica-national-development-plan-2/",
        "https://www.paho.org/en/news/5-2-2025-jamaica-completes-expanded-programme-immunization-self-assessment",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.paho.org/en/news/5-2-2025-jamaica-completes-expanded-programme-immunization-self-assessment",
        "https://www.paho.org/en/news/22-1-2025-data-driven-workshop-sets-stage-better-future-immunization-jamaica",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/caribbean-immunization-technical-advisory-group-citag-first-nitag-its-kind ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.paho.org/en/news/20-12-2024-jamaicas-expanded-immunization-programme-takes-major-step-strengthening-public ",
        "https://www.paho.org/en/news/5-2-2025-jamaica-completes-expanded-programme-immunization-self-assessment ",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.moh.gov.jm/jamaica-wins-regional-award-for-immunization-coverage/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 85,
  "country": "Japan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pj.jiho.jp/article/252211",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10050280/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.vaccines4life.com/wp-content/uploads/2021/05/NITAGs-Technical-Report-Updated-FINAL.June_.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://wwwnc.cdc.gov/eid/article/30/6/23-1454_article ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pubmed.ncbi.nlm.nih.gov/38782366/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 86,
  "country": "Jordan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://applications.emro.who.int/docs/9789290226949-eng.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes ",
        "https://jordantimes.com/news/local/measles-rubella-vaccination-campaign-aims-97-coverage-first-phase-%E2%80%94-health-ministry",
        "https://www.emro.who.int/jor/jordan-news/measles-rubella-vaccine-in-jordan-is-safe-and-effective-at-saving-childrens-lives-who-and-unicef.html",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10783979/ ",
        "https://emphnet.net/media/wqeg3h15/strengthen-the-functionality-of-the-national-immunization-technical-advisory-groups-nitag.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8238651/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10783979/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2022/strengthening-primary-health-services-to-improve-routine-immunization-coverage-for-infants-in-jordan ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10611337/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 87,
  "country": "Kazakhstan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/news-room/19-01-2024-protecting-a-generation--kazakhstan-s-commitment-to-hpv-vaccination",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/europe/news/item/23-01-2024-kazakhstan-responds-to-rapid-escalation-of-measles-cases",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/ ",
        "https://www.nitag-resource.org/resources/nitag-kazakhstan-terms-reference ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/kazakhstan/media/10491/file/Immunization%20case%20study.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/kazakhstan/kazakhstan-responds-rapid-escalation-measles-cases ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.mdpi.com/2076-393X/12/2/237 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00247-8/fulltext ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 88,
  "country": "Kenya",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://dcvmn.org/wp-content/uploads/2025/01/Kenya-Country-Profile-2024_vF.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://allianceforscience.org/blog/2023/04/kenya-ramps-up-immunization-efforts-as-who-aims-to-vaccinate-33-million-children-in-africa-by-2025/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.fondation-merieux.org/wp-content/uploads/2023/06/introducing-pcv-rotavirus-vaccine-2023-day-2-joseph-biey.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://khf.co.ke/wp-content/uploads/2021/03/Kenya-COVID_19_Vaccine-National-Deployment-and-Vaccination-Plan-08.02.2021-Portal.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pubmed.ncbi.nlm.nih.gov/32950303/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/news/kenya-launches-us9million-integrated-measles-vaccination-campaign-targeting-6-million-children",
        "https://www.health.go.ke/index.php/kenya-works-towards-transitioning-gavi-support-national-vaccination-program ",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10309080/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.medrxiv.org/content/10.1101/2025.02.11.25322096v1.full ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 89,
  "country": "Kiribati",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/country-documents/kiribati",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.undp.org/sites/g/files/zskgke326/files/2024-11/undp-pacific-chssc-report-kiribati-undp-acccountability-ecosystems.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/kiribati/kiribati-healthcare-facilities-benefit-ultra-cold-chain-equipment-support-roll-out-pfizer-vaccines ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://data.unicef.org/resources/data_explorer/unicef_f/?ag=UNICEF&df=GLOBAL_DATAFLOW&ver=1.0&dq=KIR.IM_HIB3.&startPeriod=2015&endPeriod=2023 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 90,
  "country": "Korea, North",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/dprkorea/news/detail/26-04-2023-nationwide-catch-up-immunization-campaign-in-dpr-korea",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "No up-to-date validated studies were found for North Korea within the last 2 years ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    }
  ]
}, {
  "id": 91,
  "country": "Korea, South",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11261207/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "no source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://thinkwell.global/wp-content/uploads/2019/02/Korea-Country-Report-DEC-2018-FINAL.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://jkms.org/DOIx.php?id=10.3346%2Fjkms.2024.39.e166",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.vaccines4life.com/wp-content/uploads/2020/09/Korea-Report-Design-Final.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.korea.net/Government/Briefing-Room/Press-Releases/view?articleId=7527&type=O ",
        "https://tradingeconomics.com/south-korea/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11861641/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 92,
  "country": "Kuwait",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9464581/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://tradingeconomics.com/kuwait/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html",
        "https://tradingeconomics.com/kuwait/immunization-measles-percent-of-children-ages-12-23-months-wb-data.html",
        "https://www.arabtimesonline.com/news/health-ministry-issues-new-guidance-on-child-vaccinations/",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.zawya.com/en/world/middle-east/kuwait-winter-vaccination-campaign-boosts-health-reduces-seasonal-infection-tmu2i3q1 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/kuwait/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavinpublishers.com/article/view/varicella-trends-in-kuwait-a-successful-control ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 93,
  "country": "Kyrgyzstan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://adore.ifrc.org/Download.aspx?FileId=725750 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1464370/pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10605049/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.adb.org/sites/default/files/linked-documents/55206-001-ld-04.pdf ",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2022/ensuring-equitable-access-to-vaccines-in-kyrgyzstan-through-mobile-vaccination-teams-and-community-mobilisation ",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10605049/ ",
        "https://tradingeconomics.com/kyrgyzstan/immunization-measles-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11471421/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 94,
  "country": "Laos",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9492462/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://regionalimmunisationalliance.org.au/strengthening-immunisation-policy-decision-making-lao-pdr ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://extranet.who.int/countryplanningcycles/sites/default/files/planning_cycle_repository/lao_peoples_democratic_republic/lao_cmyp_2007-2011.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.hitap.net/wp-content/uploads/2023/10/Country-Mission-Report-Lao-PDR-EE-training.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/news/media-room/government-lao-pdr-and-partners-announce-campaign-tackle-measles-and-rubella ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/laos/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.pasteur.la/activities-3/lao-lux-lab-vaccine-preventable-diseases-2021-2022/ ",
        "https://www.pasteur.la/project-carried-on-in-the-lab-26/age-stratified-seroprevalence-of-vaccine-preventable-infectious-disease-in-saravan-southern-lao-peoples-democratic-republic/ ",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 95,
  "country": "Latvia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10604541/ ",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.tiesibsargs.lv/en/areas-of-practice/what-is-national-preventive-mechanism/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/latvia/immunization-measles-percent-of-children-ages-12-23-months-wb-data.html ",
        "https://data.unicef.org/wp-content/uploads/cp/immunisation/lva.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://eng.lsm.lv/article/society/health/09.09.2024-local-diphtheria-outbreak-detected-in-latvia.a568022/? otyZiDetaKzL761wvSYesOQ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 96,
  "country": "Lebanon",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1464370/full ",
        "https://www.nitag-resource.org/sites/default/files/2020-06/FIELDGUIDE-NITAG-JUNE8.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.ifrc.org/press-release/world-bank-and-ifrc-support-independent-monitoring-covid-19-vaccine-campaign-lebanon",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://lebanon.un.org/en/226421-who-oversees-memorandum-understanding-between-task-force-global-health-and-ministry-public",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/lebanon/lebanon-launches-nation-wide-vaccination-campaign-protect-children-against-polio ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.emro.who.int/emhj-volume-30-2024/volume-30-issue-12/the-increasing-threat-of-vaccine-preventable-diseases-in-lebanon.html ",
        "https://tradingeconomics.com/lebanon/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.cambridge.org/core/journals/disaster-medicine-and-public-health-preparedness/article/measles-outbreak-in-lebanon-july-2023/E7608AE3E860789267109436C90FD80F ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 97,
  "country": "Lesotho",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2018-11/Lesotho%20Measles%20Elimination%20strategic%20plan%20WHO%20Lesotho%20final%20draft%20(2).pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://reliefweb.int/report/ethiopia/who-ethiopia-hosts-capacity-building-workshop-national-immunization-technical-advisory-group-nitags-6-countries ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/lesotho/national-measles-campaign-launched-lesotho ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.gavi.org/vaccineswork/lesotho-steps-fight-against-cervical-cancer ",
        "https://tradingeconomics.com/lesotho/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2023-08/Lesotho.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 98,
  "country": "Liberia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/countries/liberia/news/saving-liberias-future-one-measles-shot-time",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2022/liberia-liberia-takes-giant-steps-towards-90-percent-covid-19-vaccination-coverage",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.fondation-merieux.org/wp-content/uploads/2023/06/introducing-pcv-rotavirus-vaccine-2023-day-2-joseph-biey.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2022/liberia-liberia-takes-giant-steps-towards-90-percent-covid-19-vaccination-coverage",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://health.uct.ac.za/nish/articles/2023-02-22-nish-supports-5-day-capacity-building-workshop-nitag-members-botswana-liberia-south-sudan-and-uganda ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://breakthroughactionandresearch.org/wp-content/uploads/2025/01/Breakthrough-ACTION-Liberia-Our-Legacy.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2024-02/WHO%20Liberia%202023%20annual%20report_e-copy.pdf ",
        "https://tradingeconomics.com/liberia/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 99,
  "country": "Libya",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://evaluationreports.unicef.org/GetDocument?documentID=19958&fileID=51805",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://reliefweb.int/report/libya/national-center-disease-control-libya-technical-cooperation-office-annual-report-2019 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://open.unicef.org/sites/transparency/files/2023-05/Libya%20CER%202022.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11660290/ ",
        "https://libyareview.com/50396/620000-children-vaccinated-in-libyas-national-health-intitiative/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://applications.emro.who.int/docs/9789292742584-eng.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 100,
  "country": "Liechtenstein",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://ghsindex.org/wp-content/uploads/2021/12/Liechtenstein.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "2"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/liechtenstein/coronavirus-vaccination-rate ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    }
  ]
}, {
  "id": 101,
  "country": "Lithuania",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9683578/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8443398/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://ligoniukasa.lrv.lt/en/news/new-national-programme-of-immunoprophylaxis-approved ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 102,
  "country": "Luxembourg",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8443398/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.expatica.com/lu/healthcare/healthcare-services/childrens-healthcare-in-luxembourg-87598/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 103,
  "country": "Madagascar",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8753401/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/madagascar/press-releases/madagascar-launches-nationwide-measles-vaccination-campaign-protect-children",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/media/136156/file/Madagascar-2022-COAR.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.gavi.org/sites/default/files/document/targeted-country-assistance-plan-madagascar-2018--french-pdf.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.poliokit.org/news/madagascars-sbc-strategy-against-polio-engaging-schools-and-communities ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.gavi.org/vaccineswork/how-madagascar-rising-challenge-vaccinating-unprotected-kids ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 104,
  "country": "Malawi",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.path.org/our-impact/articles/reaching-9-million-children-with-vaccines-in-malawi/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://english.news.cn/africa/20250118/596511adb48f40078a0e505121f9dd41/c.html",
        "https://www.voanews.com/a/malawi-takes-steps-to-end-cholera-outbreaks-by-2030/7940991.html",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.fondation-merieux.org/wp-content/uploads/2023/06/introducing-pcv-rotavirus-vaccine-2023-day-2-joseph-biey.pdf ",
        "https://www.nitag-resource.org/sites/default/files/88420c69c4147738eb544478c16d445cdffad9cf_1.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10836352/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.coalitionagainsttyphoid.org/wp-content/uploads/2024/02/Malawi-integrated-campaign-brief-Feb2024-final.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://iffim.org/impact/after-pandemic-setback-and-natural-disasters-malawi-school-teachers-help-dial-hpv-vaccine ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2024-08/WHO%20Malawi%202023%20Annual%20Report.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 105,
  "country": "Malaysia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10038154/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.moh.gov.my/moh/resources/Pemakanan/Buku_National_Plan_of_Action_for_Nutrition_of_Malaysia_III_2016-20251.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC7482793/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://immunizationdata.who.int/global/wiise-detail-page/national-immunization-advisory-mechanism?ISO_3_CODE=MYS&YEAR=",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC7482843/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10228831/ ",
        "https://codeblue.galencentre.org/2025/02/free-influenza-vaccines-for-high-risk-seniors-amid-supply-concerns/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10355013/",
        "https://mpaeds.my/pertussis-diphtheria-measles-spiked-in-malaysia-in-2022/ ",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 106,
  "country": "Maldives",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.adb.org/sites/default/files/linked-documents/55086-001-ld-01.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/maldives/news/detail/04-10-2022-world-health-organization-supports-ministry-of-health-in-development-and-launch-of--maldives-s-electronic-immunization-registry",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/maldives/media/3441/file/Formative%20Assessment%20Report%20-%20COVID-19%20Vaccination%20Uptake%20and%20Hesitancy%20in%20Maldives.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 107,
  "country": "Mali",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://zdlh.gavi.org/country-profiles/mali",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.hitap.net/wp-content/uploads/2021/01/How-can-we-evaluate-the-potential-of-innovative-vaccine-products-and-technologies-in-resource-constrained-settings.pdf ",
        "https://www.nitag-resource.org/sites/default/files/88420c69c4147738eb544478c16d445cdffad9cf_1.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://zdlh.gavi.org/sites/default/files/2024-10/Mali_ZDLH_Semiannual_Update_October_2024.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6661538/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/europe/activities/strengthening-national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://data.unicef.org/resources/data_explorer/unicef_f/?ag=UNICEF&df=GLOBAL_DATAFLOW&ver=1.0&dq=MLI.IM_DTP3.&startPeriod=2015&endPeriod=2023 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://zdlh.gavi.org/country-profiles/mali ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11010308/ ",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 108,
  "country": "Malta",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://primaryhealthcare.gov.mt/en/clinics/primary-child-youth-health-immunisation-unit/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6661538/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/europe/activities/strengthening-national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByCountry?SelectedCountryId=147&IncludeChildAgeGroup=true&IncludeChildAgeGroup=false&IncludeAdultAgeGroup=false&ShowAdvanced=true&SelectedCountryId=147&SelectedCountryId=147 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://mcfd.org.mt/wp-content/uploads/2024/01/Annual-Report-2023-of-IDCU.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 109,
  "country": "Marshall Islands",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://rmihealth.org/media/attachments/2025/02/25/cervical-cancer-elimination-policy-and-strategy-marshall-islands_tpvm-and-unfpa_final-oct2023.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://bmjpublichealth.bmj.com/content/bmjph/1/1/e000330.full.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://ndcpartnership.org/news/marshall-islands-leads-way-high-ambition-and-calls-accelerated-action-and-development-partner ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/pacificislands/press-releases/immunization-rates-drop-6-pacific-island-countries-during-covid-19-pandemic ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 110,
  "country": "Mauritania",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/099111024161031588/pdf/P17383718d12e90e219760184e79abcd1fa.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/88420c69c4147738eb544478c16d445cdffad9cf_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/512571622828806532/Project-Information-Document-Mauritania-COVID-19-Response-Project-Additional-Financing-P176526.docx",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6661538/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/media/124676/file/Mauritania-Humanitarian-SitRep-No.1-30-June-2022.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9778331/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2023-08/Mauritania.pdf ",
        "https://www.unicef.org/media/151686/file/Mauritania-Humanitarian-SitRep-31-December-2023.pdf ",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 111,
  "country": "Mauritius",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://reliefweb.int/report/mauritius/elaboration-first-comprehensive-multi-year-plan-immunization-mauritius",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://extranet.who.int/sph/news/mauritius-strong-covid-19-vaccination-drive-reaches-76-population",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://health.govmu.org/health/wp-content/uploads/2023/03/National-Deployment-Vaccination-Plan-for-COVID-19-vaccines-in-the-Republic-of-Mauritius-2021.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://health.govmu.org/health/wp-content/uploads/2023/03/National-Deployment-Vaccination-Plan-for-COVID-19-vaccines-in-the-Republic-of-Mauritius-2021.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2021-01/WHO%20Biennial%20Report%20(002)vv.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2019-10/WHO%20MAURITIUS%20ANNUAL%20REPORT%202018.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 112,
  "country": "Mexico",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.fitchsolutions.com/bmi/healthcare/mexicos-health-budget-2025-will-focus-achieving-universal-health-coverage-19-11-2024",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.fitchsolutions.com/bmi/healthcare/mexicos-health-budget-2025-will-focus-achieving-universal-health-coverage-19-11-2024",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11265310/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6263272/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://scielosp.org/pdf/rpsp/2024.v48/e63/en ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10675656/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.scielosp.org/article/rpsp/2023.v47/e35/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 113,
  "country": "Micronesia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.ungm.org/Public/Notice/190784",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmnch.who.int/news-and-events/articles/item/who-consultant-vaccine-preventable-diseases-(vpd)-and-immunization-surveillance-pohnpei-federated-states-of-micronesia",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://bmjpublichealth.bmj.com/content/bmjph/1/1/e000330.full.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://fsmembassy.fm/all-fsm-states-begin-measles-mumps-rubella-mmr-integrated-vaccination-campaign/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://fsmembassy.fm/97-8-of-fsm-adults-aged-45-fully-vaccinated-19-boosted-41-of-fsm-adolescentsaged-12-17-fully-vaccinated-27-7-of-fsm-children-aged-5-11-fully-vaccinated/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 114,
  "country": "Moldova",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/news-room/q-and-a/detail/mongolia-who-collaboration",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/eca/media/30236/file/Balti%20District%20Root%20Cause%20Analysis%20of%20Immunization.pdf ",
        "https://www.nitag-resource.org/news/tiberiu-holban-questions-chair-nitag-moldova ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/moldova/media/11926/file/Integrating%20health%20and%20communication%20to%20achieve%20better%20results%20for%20routine%20and%20COVID-19%20immunization%20in%20Moldova.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/tiberiu-holban-questions-chair-nitag-moldova ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/708511613485648592/Additional-Financing-Stakeholder-Engagement-Plan-SEP-Moldova-Emergency-COVID-19-Response-Project-Additional-Financing-P175816.docx ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://healthjournalism.internews.org/events/vaccines-for-healthy-living-reporting-on-the-role-of-immunization-in-reducing-risk-of-disease-in-moldova/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://healthjournalism.internews.org/events/vaccines-for-healthy-living-reporting-on-the-role-of-immunization-in-reducing-risk-of-disease-in-moldova/ ",
        "https://moldova.un.org/en/259241-module-interpersonal-communication-immunization-will-be-included-subject-study-curricula ",
        "https://www.unicef.org/moldova/en/reports/immunization-intervention-led-root-cause-analysis ",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 115,
  "country": "Monaco",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://unfccc.int/sites/default/files/resource/CC-2018-1-5-Monaco-EB.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://en.gouv.mc/Portail-du-Gouvernement/Princely-Governement/News/National-information-campaign-Webinars ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "2"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    }
  ]
}, {
  "id": 116,
  "country": "Mongolia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/news-room/q-and-a/detail/mongolia-who-collaboration",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.unfpa.org/jobs/national-consultant-hpv-vaccine-introduction-mongolia",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/1bd0117377bcaeb12c4222a0389d27ac786720aa_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.aiib.org/en/projects/details/2021/_download/project-implementation-monitoring-report/August-2023/AIIB-PIMR_SBF_Mongolia_P000519_COVID-19-Vaccine-Delivery-Project_No.3_August_2023_Public-Version.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/1bd0117377bcaeb12c4222a0389d27ac786720aa_1.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.worldbank.org/en/news/press-release/2021/02/11/world-bank-approves-507-million-for-affordable-and-equitable-covid-19-vaccine-access-in-mongolia ",
        "https://pivipartners.org/mongolia/",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/mongolia/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://wwwnc.cdc.gov/eid/article/30/3/23-0864_article ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 117,
  "country": "Montenegro",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.euro.who.int/en/countries/montenegro",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.knowledge-action-portal.com/en/news_and_events/country-stories/8453",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10205045/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/montenegro/en/media/23496/file/ToR_Institutional_Consultancy_for_conducting_national_perception_surveys.pdf.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://stacks.cdc.gov/view/cdc/128788/cdc_128788_DS1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2022/introducing-hpv-vaccines-for-a-cervical-cancer-free-generation-in-montenegro ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/montenegro/en/media/23536/file/ToR_LRPS_2023_9184342_Institutional_Consultancy_for_conducting_national_perception_surveys.pdf.pdf ",
        "https://tradingeconomics.com/montenegro/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 118,
  "country": "Morocco",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/news-room/q-and-a/detail/morocco-who-collaboration",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.moroccoworldnews.com/2025/01/165472/government-expands-vaccination-campaign-to-fight-measles-epidemic/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8475612/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8968976/",
        "https://oss.signavitae.com/mre-signavitae/article/20210508-376/pdf/250-255%20SV2021040603.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8475612/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://fesnews.media/290604/2024/10/28/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11110695/ ",
        "https://tradingeconomics.com/morocco/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://trendsnafrica.com/falling-vaccination-rates-fuel-measles-outbreak-in-morocco/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 119,
  "country": "Mozambique",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gavi.org/country-documents/mozambique",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/mozambiques-grand-plan-reach-over-750000-unimmunised-children-2024",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8718423/",
        "https://www.villagereach.org/wp-content/uploads/2022/10/VR_Covid19-Case-Study_Phased-COVID-19-Vx_Final.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/mozambique-and-angola-hand-hand",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/638431651842910222/pdf/Mozambique-COVID-19-Strategic-Preparedness-and-Response-Project-Additional-Financing.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.gavi.org/vaccineswork/how-mozambique-leapt-ahead-vaccination-coverage ",
        "https://tradingeconomics.com/mozambique/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 120,
  "country": "Myanmar (Burma)",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/news-room/q-and-a/detail/myanmar-who-collaboration",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/myanmar/news/feature-stories/detail/decreasing-zero-dose-children-threefold-amidst-pandemic-and-political-unrest-in-myanmar",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "https://iris.who.int/bitstream/handle/10665/330997/SEA-Immun-134-eng.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.moi.gov.mm/moi:eng/news/2146 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11816299/ ",
        "https://tradingeconomics.com/myanmar/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/whe/him/mmr-ext-phsa-2024.pdf?sfvrsn=21aaf859_3&download=true ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 121,
  "country": "Namibia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/news-room/q-and-a/detail/namibia-who-collaboration",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2023-07/tor-template-eng-final_web.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/news/covid-19-vaccination-key-saving-lives-most-vulnerable",
        "https://journals.plos.org/plosntds/article?id=10.1371%2Fjournal.pntd.0008948",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.hrw.org/reports/pdfs/n/namibia/namibia.927/namibia927.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.thinknamibia.org.na/about ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9969425/ ",
        "https://tradingeconomics.com/namibia/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11435688/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 122,
  "country": "Nauru",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.elibrary.imf.org/view/journals/002/2022/028/article-A001-en.xml",
        "https://www.dfat.gov.au/sites/default/files/review-health-support-nauru.pdf",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.dfat.gov.au/sites/default/files/2020-21-nauru-development-program-progress-report.docx",
        "https://ghsindex.org/wp-content/uploads/2021/12/Nauru.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.undp.org/pacific/projects/nauru-accountable-and-inclusive-governance-project",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://everychildafuture.com/wp-content/uploads/2024/07/2024_06-Rotary_UNICEF-Australia_Annual-Report-FINAL.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://everychildafuture.com/wp-content/uploads/2024/07/2024_06-Rotary_UNICEF-Australia_Annual-Report-FINAL.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 123,
  "country": "Nepal",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://immunizationeconomics.org/wp-content/uploads/2024/03/NIS-case-study-Nepal-22Nov2023.pdf",
        "https://oncodaily.com/science/milestone237568",
        "https://www.who.int/nepal/news/detail/13-03-2025-photo-story--the-lifelines-of-the-hpv-vaccination-campaign",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://fwd.gov.np/wp-content/uploads/2023/12/Social-and-behavior-change-communication-strategy-to-increase-demand-for-routine-immunization-and-strengthen-community-engagemen_-ENG.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://iris.who.int/bitstream/handle/10665/330997/SEA-Immun-134-eng.pdf ",
        "https://www.nitag-resource.org/news/nepal-immunization-bill-includes-establishment-nitag ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.exemplars.health/-/media/files/vaccine-delivery/nepal/31-evm-2021-nepal-report-final-22-12-2021-1.pdf",
        "https://www.exemplars.health/topics/vaccine-delivery/nepal/what-did-nepal-do",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9486040/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/media/152701/file/Nepal-2023-COAR.pdf ",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-npl.pdf?sfvrsn=e78e9b52_3&download=true ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://fwd.gov.np/wp-content/uploads/2023/12/VPD-Surveillance-Field-Guide.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 124,
  "country": "Netherlands",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.rivm.nl/en/news/changes-in-childhood-vaccination-schedule-for-2025",
        "https://www.rivm.nl/bibliotheek/rapporten/210021012.pdf",
        "https://www.nivel.nl/sites/default/files/bestanden/1004341.pdf",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/NITAGs ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://rijksvaccinatieprogramma.nl/sites/default/files/2018-06/Thesis_NvdM.pdf",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9645343/",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.vaccinestoday.eu/stories/the-netherlands-concerns-rise-as-vaccination-falls/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.rivm.nl/bibliotheek/rapporten/2024-0072.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 125,
  "country": "New Zealand",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.health.govt.nz/publications/strategic-approach-to-immunisation-in-new-zealand-2025-2030",
        "https://www.biospectrumasia.com/news/30/25702/new-zealand-launches-strategic-approach-to-immunisation-for-next-five-years.html",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.health.govt.nz/publications/strategic-approach-to-immunisation-in-new-zealand-2025-2030",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "yes",
        "https://www.health.govt.nz/about-us/organisation-and-leadership/public-health-agency/immunisation-governance ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.vbk.nl/sites/default/files/documents/Marketing/Publicaties/Rogier%20Simons%20ea_Towards%20a%20less%20voluntary%20vaccination%20policy%20in%20the%20Netherlands_%20Findings%20from%20an%20expert%20interview%20study.pdf",
        "https://www.covid19lessons.royalcommission.nz/reports-lessons-learned/main-report/part-two/7-3-our-assessment/",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.scoop.co.nz/stories/PA2408/S00147/govt-funding-boosts-immunisation-in-high-needs-communities.htm ",
        "https://www.beehive.govt.nz/release/govt-funding-boosts-immunisation-high-needs-communities ",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.tewhatuora.govt.nz/health-services-and-programmes/vaccine-information/immunisation-coverage ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://arxiv.org/pdf/2401.09679 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 126,
  "country": "Nicaragua",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gavi.org/news/media-room/pneumococcal-vaccine-introduced-nicaragua",
        "https://www.paho.org/en/news/9-7-2024-nicaragua-moves-toward-quality-management-system-ensure-quality-safe-and-effective",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10783979/ ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6661538/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/137651654610333776/pdf/Nicaragua-COVID-19-Response-under-the-COVID-19-Strategic-Preparedness-and-Response-Program-SPRP-Additional-Financing.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/137651654610333776/txt/Nicaragua-COVID-19-Response-under-the-COVID-19-Strategic-Preparedness-and-Response-Program-SPRP-Additional-Financing.txt ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://journals.plos.org/plosntds/article/file?id=10.1371%2Fjournal.pntd.0012811&type=printable ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 127,
  "country": "Niger",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "yes",
        "https://www.gavi.org/vaccineswork/niger-operation-koutouho-reach-zero-dose-children",
        "https://www.gavi.org/vaccineswork/how-familiar-data-management-tool-brand-new-vaccine-helped-niger-beat-meningitis-outbreak",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/how-familiar-data-management-tool-brand-new-vaccine-helped-niger-beat-meningitis-outbreak",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.fondation-merieux.org/wp-content/uploads/2023/06/introducing-pcv-rotavirus-vaccine-2023-day-2-joseph-biey.pdf ",
        "https://www.nitag-resource.org/sites/default/files/2b302ead55915d61468ac747e2e437aee65871b1_1.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/how-familiar-data-management-tool-brand-new-vaccine-helped-niger-beat-meningitis-outbreak",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/niger-operation-koutouho-reach-zero-dose-children ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 128,
  "country": "Nigeria",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9485449/",
        "https://www.who.int/news-room/feature-stories/detail/breaking-barriers-building-bridges-collaborative-effort-nigeria",
        "https://zdlh.gavi.org/sites/default/files/2023-12/ZDLH_Nigeria_Situation_Analysis_2023.pdf",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://dcvmn.org/wp-content/uploads/2025/01/Nigeria-Country-Profile-2024-vf.pdf",
        "https://aeji.journals.ekb.eg/article_392829.html",
        "https://www.advocacyincubator.org/news/2025-02-18-building-health-security-in-nigeria-a-partnership-for-progress",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2b302ead55915d61468ac747e2e437aee65871b1_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.clintonhealthaccess.org/blog/pathways-to-sustainable-immunization-financing-a-nigeria-story/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2b302ead55915d61468ac747e2e437aee65871b1_1.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/countries/nigeria/news/who-partners-government-big-catch-campaign-close-immunization-coverage-gaps ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.medrxiv.org/content/10.1101/2024.02.18.24302994v1.full ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 129,
  "country": "North Macedonia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "",
        "https://www.who.int/europe/news-room/30-09-2024-north-macedonia-s-health-system-strengthened-by-usaid-project-s-immunization-efforts",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/europe/news-room/30-09-2024-north-macedonia-s-health-system-strengthened-by-usaid-project-s-immunization-efforts",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.undp.org/sites/g/files/zskgke326/files/2024-05/2_Audit_report_Preparedness%20of%20the%20Republic%20of%20North%20Macedonia%20for%20implementation%20of%20the%20SDG%20until%202030_EN.pdf ",
        "https://extranet.who.int/sph/sites/default/files/document-library/document/North%20Macedonia%20Publication%20NAPHS_WEB_ENG_Final.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://knowledgesuccess.org/wp-content/uploads/2024/01/N-Macedonia-Case-Study-English-Final.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pivipartners.org/slideshow-strengthening-vaccination-in-high-risk-groups-in-north-macedonia/ ",
        "https://www.who.int/europe/news-room/30-09-2024-north-macedonia-s-health-system-strengthened-by-usaid-project-s-immunization-efforts ",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 130,
  "country": "Norway",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/8790c9cc0d447705ac4df723a4bb9db418b95d48_1.pdf ",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.fhi.no/en/va/innforing-av-nye-vaksiner/scientific-reference-group-for-national-immunisation-programs/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.vaccinealliance.org/press/press_norway.html",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.fhi.no/en/publ/2024/The-Childhood-Immunization-Programme-2023/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 131,
  "country": "Oman",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/c75b2f4eca3fa2e4d2a810b00de83d7d6a2ed0d5_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9194916/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/182e06d969d04960d10df1f1a974246665032bcf_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/182e06d969d04960d10df1f1a974246665032bcf_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://data.unicef.org/wp-content/uploads/cp/immunisation/omn.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 132,
  "country": "Pakistan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "no source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://emphnet.net/media/wqeg3h15/strengthen-the-functionality-of-the-national-immunization-technical-advisory-groups-nitag.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10982083/",
        "https://pakistan.un.org/en/291370-media-update-united-nations-pakistan-21-march-2025",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pid.gov.pk/site/press_detail/26797 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11679383/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/099610104112220455/pdf/P16773308140f90eb0aef509d35d40acb47.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 133,
  "country": "Palau",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2023-07/tor-template-eng-final_web.pdf ",
        "https://www.nitag-resource.org/sites/default/files/2020-06/FIELDGUIDE-NITAG-JUNE8.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-plw.pdf?sfvrsn=29d2a68a_3&download=true",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.palauhealth.org/NCD/NCD%20Funds%20Policies%20and%20Guidelines_Dcember%202024.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://archive.cdc.gov/www_cdc_gov/vaccines/covid-19/downloads/palau-jurisdiction-executive-summary.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/palau/immunization-measles-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11563571/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 134,
  "country": "Panama",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.iadb.org/en/news/idb-approves-30-million-project-help-panama-get-vaccines-address-covid-19",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.iadb.org/en/news/idb-approves-30-million-project-help-panama-get-vaccines-address-covid-19",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10850980/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/panama/idb-approves-30-million-project-help-panama-get-vaccines-address-covid-19",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.worldbank.org/en/news/press-release/2022/03/28/banco-mundial-aportar-us-100-millones-para-apoyar-los-esfuerzos-de-vacunacion-contra-la-covid-19-en-panama ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/panama/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10789724/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 135,
  "country": "Papua New Guinea",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/papuanewguinea/news/detail/24-02-2025-who-allocates-pgk-5.9-million-to-boost-routine-immunisation-in-12-provinces-in-papua-new-guinea",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/papuanewguinea/news/detail/24-02-2025-who-allocates-pgk-5.9-million-to-boost-routine-immunisation-in-12-provinces-in-papua-new-guinea",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/papuanewguinea/news/detail/24-02-2025-who-allocates-pgk-5.9-million-to-boost-routine-immunisation-in-12-provinces-in-papua-new-guinea",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://eiti.org/sites/default/files/attachments/png_eiti_national_policy_final_2019.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.dfat.gov.au/sites/default/files/red-strategy-png-report.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.unicef.org/media/152186/file/Papua-New-Guinea-2023-COAR.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 136,
  "country": "Paraguay",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2022/access-to-vaccines-for-indigenous-populations-in-paraguay--a-joint-effort",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2023-09/5_GNNmeeting_Amman_2023_FV.pdf ",
        "https://www.nitag-resource.org/sites/default/files/2020-06/FIELDGUIDE-NITAG-JUNE8.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2022/access-to-vaccines-for-indigenous-populations-in-paraguay--a-joint-effort",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2022/access-to-vaccines-for-indigenous-populations-in-paraguay--a-joint-effort ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://journal.paho.org/en/articles/impact-new-intervention-model-increase-vaccination-coverage-paraguay-2023",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 137,
  "country": "Peru",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://p4h.world/en/documents/perus-ministry-of-health-strategic-plan-2025-2030-approved/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://en.wikipedia.org/wiki/COVID-19_vaccination_in_Peru",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.oecd.org/content/dam/oecd/en/publications/reports/2024/12/towards-a-national-integrity-and-transparency-system-in-peru_0f35258c/4207602e-en.pdf ",
        "https://www.nitag-resource.org/sites/default/files/2020-06/FIELDGUIDE-NITAG-JUNE8.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-per.pdf?sfvrsn=94603836_3&download=true",
        "https://www.exemplars.health/topics/under-five-mortality/peru/what-did-peru-do",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.medrxiv.org/content/10.1101/2024.06.03.24308410v1 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 138,
  "country": "Philippines",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gmanetwork.com/news/topstories/nation/934599/doh-child-immunization-philippines-national-immunization-summit-2025/story/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "no source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://aaspjournal.org/uploads/155/5922_pdf.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/philippines/news/detail/30-01-2025-doh--unicef--who-highlight-key-strategies-to-achieve-95--child-immunization-in-the-philippines",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.aaspjournal.org/uploads/155/5922_pdf.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.vaccines4life.com/wp-content/uploads/2021/05/SAAV_Environmental-Scan_Philippines.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11625405/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 139,
  "country": "Poland",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.vaccinestoday.eu/stories/poland-is-prioritising-disease-prevention-at-all-ages/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "https://www.who.int/europe/publications/template--terms-of-reference-of-the-national-immunization-technical-advisory-group ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10975328/ ",
        "https://www.vaccines4life.com/wp-content/uploads/2021/05/SAAV_Environmental-Scan_Poland.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://stat.gov.pl/en/topics/health/health/vaccinations-of-children-and-youth,5,5.html?pdf=1",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 140,
  "country": "Portugal",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.vaccinestoday.eu/stories/portugal-in-focus-public-trust-drives-vaccine-uptake-at-all-ages/",
        "https://www.gavi.org/investing-gavi/funding/donor-profiles/portugal",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags)",
        "https://www.who.int/europe/publications/template--terms-of-reference-of-the-national-immunization-technical-advisory-group ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www2.gov.pt/en-GB/noticias/plano-de-vacinacao-para-a-covid-19",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.vaccinestoday.eu/stories/portugal-in-focus-public-trust-drives-vaccine-uptake-at-all-ages/ ",
        "https://www.opengovpartnership.org/documents/portugal-action-plan-review-2023-2027/ ",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.vaccinestoday.eu/stories/portugal-in-focus-public-trust-drives-vaccine-uptake-at-all-ages/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 141,
  "country": "Qatar",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://thepeninsulaqatar.com/article/24/04/2024/vaccine-awareness-campaign-launched-as-qatar-marks-world-immunisation-week",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "No source",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.sherborneqatar.org/userfiles/ssqmvc/documents/2024/SQ%20Medical%20Policy%20%20June%202024.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://dig.watch/resource/qatar-digital-government-strategy-2023-2025 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/qatar/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 142,
  "country": "Romania",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://issuemonitoring.eu/en/romanias-health-sector-opportunities-and-challenges/",
        "https://www.unicef.org/romania/media/15486/file/OM_MN_13012025-EN-v4.pdf.pdf",
        "https://eurohealthobservatory.who.int/monitors/health-systems-monitor/analyses/hspm/romania-2016/national-vaccination-strategy-2023-2030",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10604541/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/romania/media/15486/file/OM_MN_13012025-EN-v4.pdf.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10604541/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.unicef.org/romania/media/15486/file/OM_MN_13012025-EN-v4.pdf.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/romania/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11734985/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 143,
  "country": "Russia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.karmactive.com/russia-to-offer-free-mrna-cancer-vaccine-for-patients-starting-2025-amid-tumor-suppression-breakthroughs/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "No source",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/russia/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.epidemvac.ru/jour?locale=en_US ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 144,
  "country": "Rwanda",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://p4h.world/en/news/rwanda-unveils-fifth-health-sector-strategic-plan-to-advance-universal-health-coverage/",
        "https://www.moh.gov.rw/news-detail/rwanda-unveils-fifth-health-sector-strategiec-plan-to-advance-universal-health-coverage",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "no source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://reachalliance.org/wp-content/uploads/2020/02/Rwanda-Published-Manuscript.pdf ",
        "https://reachalliance.org/wp-content/uploads/2017/03/ReachProject-Rwanda3-1.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://reachalliance.org/case-study/expanded-program-on-immunization-near-universal-childhood-vaccination-rates/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://reachalliance.org/wp-content/uploads/2020/02/Rwanda-Published-Manuscript.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://resolvetosavelives.org/about/success-stories/campaigns-build-vaccine-confidence-in-rwanda-and-uganda/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://reachalliance.org/case-study/expanded-program-on-immunization-near-universal-childhood-vaccination-rates/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://rbc.gov.rw/fileadmin/user_upload/report_2024/Knowledge_Attitudes_Practices_Behaviours_on_Immunization_in_Rwanda_Final_Report_19.05.2021_compressed.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 145,
  "country": "Saint Kitts and Nevis",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.paho.org/en/news/19-8-2024-antigua-and-barbuda-and-st-kitts-and-nevis-leading-global-vaccination-rates",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.paho.org/en/news/3-5-2023-st-kitts-and-nevis-celebrates-vaccination-week-americas",
        "https://www.paho.org/en/news/5-11-2024-caribbean-immunization-managers-commended-beginning-turnaround-vaccination-coverage",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.paho.org/sites/default/files/2021-10/saint-kitts-nevis-2020-epi-country-report-english.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.sknis.gov.kn/2024/12/03/government-of-st-kitts-and-nevis-to-share-findings-from-90-day-crime-and-violence-campaign/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-kna.pdf?sfvrsn=8aae8bc6_3&download=true ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 146,
  "country": "Saint Lucia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.paho.org/en/news/21-2-2025-saint-lucia-advances-immunization-programme-paho-supported-comprehensive-costing",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2020-06/FIELDGUIDE-NITAG-JUNE8.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.govt.lc/news/ministry-of-health-begins-childhood-vaccination-campaign-tomorrow ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/saint-lucia/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 147,
  "country": "Saint Vincent and the Grenadines",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.iccp-portal.org/system/files/plans/VCT_B3_NATIONAL%20ACTION%20PLAN%20FOR%20THE%20PREVENTION%20AND%20CONTROL%20OF%20NCDS%202017-2025.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://unfccc.int/sites/default/files/resource/NAP-Saint-Vincent-and-the-Grenadines-2019.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://caribbean.un.org/en/160835-un-launches-initiative-tackle-vaccine-hesitancy-and-increase-covid-19-vaccine-uptake-eastern ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-vct.pdf?sfvrsn=19c94684_3&download=true ",
        "https://tradingeconomics.com/st-vincent-and-the-grenadines/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 148,
  "country": "Samoa",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "no source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/westernpacific/newsroom/feature-stories/item/samoa-strengthens-its-vaccination-programme",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.adb.org/sites/default/files/linked-documents/50282-003-sd-04.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/niue/news/feature-stories/detail/samoa-s-two-day-vaccination-lockdown-helps-to-boost-coverage ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.who.int/westernpacific/newsroom/feature-stories/item/samoa-strengthens-its-vaccination-programme ",
        "https://tradingeconomics.com/samoa/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.coalitionagainsttyphoid.org/amidst-a-global-pandemic-samoa-rolls-out-tcv-and-other-new-vaccines/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 149,
  "country": "San Marino",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-smr.pdf?sfvrsn=befe930f_3&download=true",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "3"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.oscepa.org/en/documents/special-representatives/disinformation-and-propaganda/4135-resolution-introduced-by-oscar-mina-adopted-by-the-parliament-of-san-marino-25-january-2021/file ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "3"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/san-marino/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "3"
    }
  ]
}, {
  "id": 150,
  "country": "Sao Tome and Principe",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://reliefweb.int/report/sao-tome-and-principe/celebration-50th-anniversary-expanded-immunization-programmme-sao-tome-and-principe",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://unfccc.int/sites/default/files/resource/tasr1_STP.pdf ",
        "https://www.afro.who.int/sites/default/files/2024-02/HIGHLIGHTS%20OF%20THE%202022%20-%202023%20BIENNIUM%20IN%20S%C3%83O%20TOM%C3%89%20AND%20PRINCIPE%20Final.pdf ",
        "https://www.gavi.org/country-documents/sao-tome-and-principe ",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/country-documents/sao-tome-and-principe",
        "https://www.unicef.org/media/141051/file/Sao-Tome-and-Principe-2022-COAR.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.linkedimmunisation.org/wp-content/uploads/2018/03/LNCT_Sao-Tome_Managing-the-Gavi-transition-poster-Dec-2017_ENG.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/news/sao-tome-and-principe-reaches-first-global-target-vaccination-against-covid-19-vaccinating ",
        "https://reliefweb.int/report/sao-tome-and-principe/celebration-50th-anniversary-expanded-immunization-programmme-sao-tome-and-principe ",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-stp.pdf?sfvrsn=c523e824_3&download=true ",
        "https://tradingeconomics.com/sao-tome-and-principe/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2023-08/Sao%20Tome.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 151,
  "country": "Saudi Arabia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2024-11-11-002.aspx",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "No source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.sfda.gov.sa/sites/default/files/2021-03/Drug-resourec-2134-EN.pdf ",
        "https://applications.emro.who.int/docs/WHOEMCSR746E-eng.pdf?ua=1 ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.sfda.gov.sa/sites/default/files/2024-11/Drug-resoyrce-2143.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10919942/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/saudi-arabia/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "https://www.emro.who.int/emhj-volume-29-2023/volume-29-issue-7/improving-covid-19-vaccine-uptake-lessons-from-an-academic-institution-in-saudi-arabia.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pubmed.ncbi.nlm.nih.gov/39643949/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 152,
  "country": "Senegal",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.exemplars.health/topics/vaccine-delivery/senegal",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://english.news.cn/africa/20241203/97fb606dcca54361becbfa8479641f6e/c.html",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6143477/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.exemplars.health/topics/vaccine-delivery/senegal",
        "https://www.exemplars.health/topics/vaccine-delivery/senegal/what-did-senegal-do",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6143477/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10551957/ ",
        "https://english.news.cn/africa/20241203/97fb606dcca54361becbfa8479641f6e/c.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2023-08/Senegal.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 153,
  "country": "Serbia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/news-room/05-04-2024-strategic-outreach-in-serbia--reaching-unvaccinated-children-with-measles-vaccine",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9713902/ ",
        "https://www.nitag-resource.org/resources/developing-covid-19-vaccine-recommendations-during-pandemic-experience-serbias-expert ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.srbija.gov.rs/vest/en/172918/campaign-for-vaccination-of-young-people-aged-16-to-25-starting-tomorrow.php",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.1056670/full",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9713902/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/news-room/05-04-2024-strategic-outreach-in-serbia--reaching-unvaccinated-children-with-measles-vaccine ",
        "https://usaidmomentum.org/wp-content/uploads/2024/08/SerbiaReport_final_508.pdf",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/seychelles/seychelles-celebrates-50-years-saving-childrens-lives-through-immunization ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 154,
  "country": "Seychelles",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.afro.who.int/countries/seychelles/news/seychelles-paving-way-sustained-immunization-efforts-2030-whos-technical-assistance-seychelles",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/countries/seychelles/news/seychelles-paving-way-sustained-immunization-efforts-2030-whos-technical-assistance-seychelles",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/countries/seychelles/news/seychelles-paving-way-sustained-immunization-efforts-2030-whos-technical-assistance-seychelles",
        "https://www.cabri-sbo.org/uploads/files/Documents/Seychelles-presentation-Session-2-English.pptx",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/countries/seychelles/news/seychelles-paving-way-sustained-immunization-efforts-2030-whos-technical-assistance-seychelles ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0299747 ",
        "https://www.afro.who.int/countries/seychelles/news/seychelles-paving-way-sustained-immunization-efforts-2030-whos-technical-assistance-seychelles ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 155,
  "country": "Sierra Leone",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.childhealthtaskforce.org/sites/default/files/2024-03/Sierra%20Leone%20Child%20Survival%20Action%20Plan%202023-2025.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.childhealthtaskforce.org/sites/default/files/2024-03/Sierra%20Leone%20Child%20Survival%20Action%20Plan%202023-2025.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://extranet.who.int/countryplanningcycles/sites/default/files/country_docs/Sierra%20Leone/cmyp-_2012-2016_narrative_for_sierra_leone_final_updated_on_the_23_jan_2014.pdf",
        "https://icap.columbia.edu/news-events/with-icap-support-sierra-leone-improves-childhood-vaccination-uptake-within-a-year/",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://icap.columbia.edu/news-events/with-icap-support-sierra-leone-improves-childhood-vaccination-uptake-within-a-year/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2023-07/WHO%20Sierra%20Leone%20Annual%20Report%20for%202022.pdf ",
        "https://tradingeconomics.com/sierra-leone/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2023-08/Sierra%20Leone.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 156,
  "country": "Singapore",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No specific information available in the provided sources",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No ",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.moh.gov.sg/seeking-healthcare/overview-of-diseases/communicable-diseases/nationally-recommended-vaccines ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.moh.gov.sg/newsroom/ministry-of-health-s-response-to-call-to-suspend-covid-19-vaccination",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No information available",
        "No information available",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.tech.gov.sg/our-digital-government-efforts/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10392729/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 157,
  "country": "Slovakia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://eurohealthnet-magazine.eu/increasing-uptake-the-impact-of-slovakias-free-hpv-vaccination-rollout/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://eurohealthnet-magazine.eu/increasing-uptake-the-impact-of-slovakias-free-hpv-vaccination-rollout/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10604541/ ",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10205045/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.euractiv.com/section/health-consumers/news/slovakias-long-standing-vaccination-issue-gets-urgently-problematic/ ",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-svk.pdf?sfvrsn=421a9d35_3&download=true ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 158,
  "country": "Slovenia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10604541/ ",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.gov.si/en/topics/vaccination/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10205045/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.reportlinker.com/clp/country/594845/726389 ",
        "https://tradingeconomics.com/slovenia/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 159,
  "country": "Solomon Islands",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/westernpacific/newsroom/feature-stories/item/let-s-talk-about-it-improving-immunization-coverage-in-the-solomon-islands",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://gco.iarc.fr/media/covid/factsheets/90-SLB-solomon_islands.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "yes",
        "https://communityengagementhub.org/resource/strengthening-and-expanding-feedback-mechanisms-in-the-solomon-islands/",
        "https://solomons.gov.sb/epi-one-of-the-key-pillars-of-primary-health-care-in-the-solomon-islands/",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.who.int/westernpacific/newsroom/feature-stories/item/let-s-talk-about-it-improving-immunization-coverage-in-the-solomon-islands ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pubmed.ncbi.nlm.nih.gov/39318888/ ",
        "https://tradingeconomics.com/solomon-islands/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://gco.iarc.fr/media/covid/factsheets/90-SLB-solomon_islands.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 160,
  "country": "Somalia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://reliefweb.int/report/somalia/prime-minister-launches-somalia-immunization-and-polio-eradication-task-force-calling-swifter-action-end-vaccine-preventable-disease-outbreaks",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/somalia/full-covid-19-vaccination-sight-70-somalias-population",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.linkedin.com/posts/khadar-mohamud-hared-704b67121_immunization-somalia-activity-7256251439809740800-gwSg ",
        "https://www.ftlsomalia.com/week-long-nitag-workshop-gets-underway-in-mogadishu/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.unicef.org/media/168076/file/Somalia-Humanitarian-SitRep-No.12-(Year-End)-01-January-to-31-December-2024.pdf.pdf",
        "https://reliefweb.int/report/somalia/full-covid-19-vaccination-sight-70-somalias-population",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/606101630563573042/pdf/Project-Information-Document-Somalia-COVID-19-Emergency-Vaccination-Project-P176956.pdf ",
        "https://www.sabin.org/resources/supporting-the-backbone-of-public-health-in-somalia/ ",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11907845/ ",
        "https://tradingeconomics.com/somalia/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11732465/ ",
        "https://www.emro.who.int/somalia/priority-areas/immunization.html ",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 161,
  "country": "South Africa",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://knowledgehub.health.gov.za/system/files/2024-05/VACCINE%20HESITANCY%20WEBINAR_OVERVIEW%20OF%20EPI_MAY_2024_FINAL.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://en.wikipedia.org/wiki/COVID-19_vaccination_in_South_Africa",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/a1c99f72632c89622c12a89dc8355b6839099850_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.sahpra.org.za/document/vaccine-safety-surveillance-vss-in-south-africa/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/88420c69c4147738eb544478c16d445cdffad9cf_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6284504/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://theconversation.com/south-africa-has-a-good-childhood-vaccination-system-whats-stopping-it-from-being-great-237336 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nicd.ac.za/nicd-germs-sa-surveillance-report-reveals-a-rise-in-vaccine-preventable-diseases/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 162,
  "country": "South Sudan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.savethechildren.net/blog/leaving-no-one-behind-universal-health-coverage-agenda-un-general-assembly-must-deliver-action",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/south-sudan-nitag-now-re-established ",
        "https://www.nitag-resource.org/news/high-level-commitment-strengthening-nitags-despite-political-instability-example-south-sudan ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://humanitarianaction.info/plan/1223/document/humanitarian-needs-and-response-plan-south-sudan-2025/article/35-health-1",
        "https://reliefweb.int/report/south-sudan/south-sudans-fight-against-covid-19-and-efforts-safeguard-community-vaccine-preventable-diseases",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/south-sudan-nitag-now-re-established ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/news/high-level-commitment-strengthening-nitags-despite-political-instability-example-south-sudan ",
        "https://www.nitag-resource.org/news/south-sudan-nitag-now-re-established ",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/south-sudan/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2023-08/South%20Sudan.pdf ",
        "https://www.msf.org/urgent-vaccination-campaign-needed-halt-deadly-measles-outbreak-south-sudan ",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 163,
  "country": "Spain",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.vaccinestoday.eu/stories/spotlight-on-spain-building-life-course-vaccination-on-a-strong-foundation/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.vaccinestoday.eu/stories/spotlight-on-spain-building-life-course-vaccination-on-a-strong-foundation/ ",
        "https://ojs.sanidad.gob.es/index.php/resp/article/download/780/1115/3578 ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.analesdepediatria.org/en-immunisation-schedule-pediatric-spanish-association-articulo-S2341287924003296",
        "https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance/networks/vaccine-safety-net/vsn-members/ministry-of-health-of-spain",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.vaccinestoday.eu/stories/spotlight-on-spain-building-life-course-vaccination-on-a-strong-foundation/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.vaccinestoday.eu/stories/spotlight-on-spain-building-life-course-vaccination-on-a-strong-foundation/ ",
        "https://ojs.sanidad.gob.es/index.php/resp/article/download/780/1115/3578 ",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://data.unicef.org/wp-content/uploads/cp/immunisation/esp.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pubmed.ncbi.nlm.nih.gov/39103777/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 164,
  "country": "Sri Lanka",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.unicef.org/rosa/media/5191/file/UNICEF_Sustaining_Vaccination_Coverage_SriLanka.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.sdc.gov.lk/en/event/148",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.unicef.org/rosa/media/5191/file/UNICEF_Sustaining_Vaccination_Coverage_SriLanka.pdf",
        "https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2021/sri-lanka",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://data.unicef.org/wp-content/uploads/cp/immunisation/lka.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 165,
  "country": "Sudan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gavi.org/news/media-room/gavi-save-children-and-unicef-collaborate-strengthen-immunization-services-sudan",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/crossing-frontlines-deliver-life-saving-vaccines-sudan",
        "https://sudan.un.org/en/282834-sudan-rolls-out-first-malaria-vaccines",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8522678/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.gavi.org/country-documents/sudan",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://emphnet.net/media/gsmjcwuc/gavi_y23_sudan-pef-tca_-project-brief_final.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://unfccc.int/sites/default/files/NDC/2022-10/Sudan%20Updated%20First%20NDC-12102021.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.dabangasudan.org/en/all-news/article/un-700k-children-unvaccinated-as-immunisation-plummets-in-sudan ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/2021-dha-docs/20250310_phsa_sudan-conflict.pdf?sfvrsn=d1b69fc1_3&download=true ",
        "https://www.unicef.org/media/167721/file/UNICEF%20South%20Sudan%20Humanitarian%20Situation%20Report%20No.%2012%20-%20Jan%20-%20Dec%202024.pdf.pdf ",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 166,
  "country": "Suriname",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "yes",
        "https://www.paho.org/en/news/19-6-2023-paho-evaluates-national-immunization-program-through-field-assessment-activities",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://evaluationreports.unicef.org/GetDocument?documentID=18948&fileID=50149 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.paho.org/en/news/25-4-2023-vaccination-week-americas-2023-launched-suriname",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.medrxiv.org/content/10.1101/2024.01.09.24301061v1.full.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 167,
  "country": "Sweden",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/changing-national-vaccination-programmes-sweden",
        "https://www.nitag-resource.org/news/nitag-sweden",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://en.wikipedia.org/wiki/COVID-19_vaccination_in_Sweden",
        "https://www.pathogens.se/dashboards/recovac/",
        "https://academic.oup.com/book/44441/chapter/376663674",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/changing-national-vaccination-programmes-sweden ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/news/changing-national-vaccination-programmes-sweden ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.pathogens.se/dashboards/vaccines/ ",
        "https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/vaccinations/vaccination-programmes/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nature.com/articles/s41598-025-86968-y  ",
        "https://haematologica.org/article/view/haematol.2024.285161 ",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 168,
  "country": "Switzerland",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/5e5c9ffcc39ab91a02fd4e299236a2fdde0ceb4c_2.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://smw.ch/index.php/smw/article/view/3120",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.bag.admin.ch/bag/en/home/strategie-und-politik/nationale-gesundheitsstrategien/nationale-strategie-impfungen-nsi.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.bag.admin.ch/bag/en/home/strategie-und-politik/nationale-gesundheitsstrategien/nationale-strategie-impfungen-nsi.html ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://reisemedizin.uzh.ch/en/blog/interview_phung_lang ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10747840/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10570900/ ",
        "https://www.bag.admin.ch/bag/en/home/gesund-leben/gesundheitsfoerderung-und-praevention/impfungen-prophylaxe.html ",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 169,
  "country": "Syria",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "yes",
        "https://www.unicef.org/media/167346/file/Syria-Humanitarian-SitRep-No.-05,-20-January-2025.pdf.pdf",
        "https://www.gavi.org/news/media-room/big-catch-syria-rolls-out-initiative-reach-millions-children-missed-during-covid-19",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://emphnet.net/media/wjll12ji/32_2021_5-2-nitag-emr_project-brief.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.emro.who.int/syria/news/syria-completes-the-first-phase-of-covid-19-vaccination-campaign.html ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.gavi.org/news/media-room/big-catch-syria-rolls-out-initiative-reach-millions-children-missed-during-covid-19 ",
        "https://cdn.who.int/media/docs/default-source/country-profiles/immunization/2024-country-profiles/immunization-2024-syr.pdf?sfvrsn=9143b8d4_3&download=true ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 170,
  "country": "Taiwan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11209125/",
        "https://pubmed.ncbi.nlm.nih.gov/38932320/",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://caribbeannewsglobal.com/taiwans-smart-technology-and-innovative-economy-core-to-national-development-plan-and-development-strategies/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.cdc.gov.tw/En/Bulletin/Detail/i6vk975MaKP1ajyXsKWxcQ?typeid=158 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.cdc.gov.tw/Uploads/infectionreport/b0b27d2c-6e9d-4533-98d1-3228807445b7.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.cdc.gov.tw/Uploads/infectionreport/b0b27d2c-6e9d-4533-98d1-3228807445b7.pdf",
        "https://pubmed.ncbi.nlm.nih.gov/39267943/ ",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 171,
  "country": "Tajikistan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.worldbank.org/en/results/2023/11/24/building-a-stronger-tajikistan-in-the-wake-of-the-covid-19-crisis",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10205045/ ",
        "https://www.gavi.org/sites/default/files/document/2022/Multi-stakeholder-dialogue-Tajikistan-2020.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.gavi.org/sites/default/files/document/2022/Multi-stakeholder-dialogue-Tajikistan-2020.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10205045/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/sites/default/files/document/2022/Multi-stakeholder-dialogue-Tajikistan-2020.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/tajikistan/immunization-pol3-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 172,
  "country": "Tanzania",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "No source provided",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/tanzanias-big-catch-gains-ground",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2023-07/TITAG%20ASSESSMENT_REPORT_DRAFT120523%20VF_Ok.pdf",
        "https://www.nitag-resource.org/news/newly-established-tanzania-nitag-oriented-nitag-functioning ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://extranet.who.int/countryplanningcycles/sites/default/files/planning_cycle_repository/tanzania/tanzania_cmyp_doc.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/newly-established-tanzania-nitag-oriented-nitag-functioning ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://thecompassforsbc.org/project-examples/tanzania-capacity-and-communication-project-tccp-list-campaigns ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11123454/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10784152/ ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11123454/ ",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 173,
  "country": "Thailand",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.bangkokpost.com/thailand/pr/2693929/thailands-vaccination-drive-gains-momentum-in-2023",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.bangkokpost.com/thailand/pr/2969281/thailand-expands-vaccine-procurement-for-young-children-",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.ijhpm.com/article_3740_c169818f2463aeab146287f1ac8c643e.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10783979/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.bangkokpost.com/thailand/pr/2693929/thailands-vaccination-drive-gains-momentum-in-2023 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.bangkokpost.com/thailand/pr/2693929/thailands-vaccination-drive-gains-momentum-in-2023 ",
        "https://outbreaknewstoday.substack.com/p/thailand-reports-an-increase-in-many ",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 174,
  "country": "Timor-Leste",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.technet-21.org/en/community/blogs-newsletters/timor-leste-conducts-comprehensive-immunization-and-vaccine-surveillance-review?layout=listings",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://en.tatoli.tl/2023/01/12/timor-leste-launches-national-integrated-vaccination-campaign/17/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/all-countries-searo-region-have-nitag ",
        "https://www.linkedimmunisation.org/wp-content/uploads/2018/02/LNCT_Timor-Leste_Managing-the-Gavi-transition-poster-Dec-2017_ENG.pdf ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.who.int/timorleste/news/detail/27-10-2024-joint-national-and-international-review-of-immunization-systems-after-9-years-in-timor-leste",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/all-countries-searo-region-have-nitag ",
        "https://regionalimmunisationalliance.org.au/aria-region-immunisation-and-vaccine-courses-timor-leste ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://cdn.who.int/media/docs/default-source/searo/evaluation-reports/evaluation-of-national-immunization-technical-advisory-groups-(nitag)-in-south-east-asia-region.pdf?sfvrsn=4bd8990e_5 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.who.int/timorleste/news/detail/28-04-2023-timor-leste-s-health-workers-use-digital-tools-to-assess-immunization-coverage ",
        "https://www.who.int/timorleste/news/detail/24-04-2024-world-immunization-week--timor-leste-s-focused-efforts-in-immunization-are-vital-pillar-of-public-health ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10201250/",
        "https://www.who.int/timorleste/news/detail/24-04-2024-world-immunization-week--timor-leste-s-focused-efforts-in-immunization-are-vital-pillar-of-public-health ",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 175,
  "country": "Togo",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.acceleratehss.org/wp-content/uploads/2023/11/Accelerator_Togo-Report-2023_web-version.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/reduce-waste-boost-coverage-togo_adopts-smaller-five-dose-vials",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.fondation-merieux.org/wp-content/uploads/2023/06/introducing-pcv-rotavirus-vaccine-2023-day-2-joseph-biey.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.acceleratehss.org/wp-content/uploads/2023/11/Accelerator_Togo-Report-2023_web-version.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/46bb8c6ff2efadd38335fe2481d2a9037fbc9520_1.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.actntdswest.org/sites/default/files/inline-files/Togo-FY%2025%20work%20plan.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/togo/immunization-dpt-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/news/media-room/togo-introduces-human-papillomavirus-vaccine-protect-adolescent-girls-leading",
        "https://www.acceleratehss.org/wp-content/uploads/2023/11/Accelerator_Togo-Report-2023_web-version.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 176,
  "country": "Tonga",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.adb.org/sites/default/files/linked-documents/50282-003-sd-05.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "yes",
        "https://www.adb.org/sites/default/files/linked-documents/50282-003-sd-05.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.adb.org/sites/default/files/linked-documents/50282-003-sd-05.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/tonga/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 177,
  "country": "Trinidad and Tobago",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/caribbean-immunization-technical-advisory-group-citag-first-nitag-its-kind ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://sta.uwi.edu/fms/sites/default/files/fms/documents/COVID-19%20Vaccines%20-%20Addressing%20Hesitancy%202021050302.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/caribbean-immunization-technical-advisory-group-citag-first-nitag-its-kind ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://health.gov.tt/ncd-microsite/trinidad-and-tobagos-response-to-ncds-0 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/trinidad-and-tobago/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 178,
  "country": "Tunisia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.medrxiv.org/content/10.1101/2024.09.17.24313756v2.full",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/resources/ministerial-decree-establishing-technical-immunization-committee-tunisia ",
        "https://www.agenzianova.com/en/news/tunisia-un-nuovo-decreto-ministeriale-aggiorna-lelenco-dei-vaccini-obbligatori/",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://cdn.who.int/media/docs/default-source/immunization/school-vaccination/tunisia-school-immunization-2010.pdf?sfvrsn=b4f4d8be_3",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC4027262/",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6143477/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.worldbank.org/en/news/press-release/2021/03/26/world-bank-approves-us-100-million-to-support-covid-19-vaccine-deployment-in-tunisia ",
        "https://extranet.who.int/sph/news/tunisia-receives-first-batch-covid-19-vaccines-through-covax-facility ",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/tunisia/immunization-hepb3-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.medrxiv.org/content/10.1101/2024.09.17.24313756v2.full",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC7750331/",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 179,
  "country": "Turkey",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "6"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://disab.saglik.gov.tr/EN-77506/national-immunization-technical-advisory-group-nitag-turkey-meeting.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10604964/",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC7227707/",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://disab.saglik.gov.tr/EN-77506/national-immunization-technical-advisory-group-nitag-turkey-meeting.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/327371653594411250/pdf/Turkey-Emergency-COVID-19-Health-Project-Additional-Financing-and-Restructuring.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/turkey/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC7750331/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "6"
    }
  ]
}, {
  "id": 180,
  "country": "Turkmenistan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.ungeneva.org/en/news-media/meeting-summary/2024/08/examen-de-turkmenistan-au-crc-le-pays-accompli-beaucoup-de",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "yes",
        "https://www.undp.org/sites/g/files/zskgke326/files/2022-05/UNDP-Turkmenistan-COVID19-ESMF-ENG-2022.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://ghpp.de/en/projects/euro-nitags/ ",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://turkmenistan.un.org/en/10703-turkmenistan-receives-unicef%E2%80%99s-award-letter-sustaining-high-immunization-rates ",
        "https://tdh.gov.tm/en/post/18924/turkmenistan-is-awarded-with-the-unicef-certificate-for-high-results-in-children-immunization ",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/turkmenistan/immunization-bcg-percent-of-one-year-old-children-wb-data.html",
        "https://progres.online/society/every-dose-counts-gaps-in-turkmenistans-immunization-despite-high-coverage/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 181,
  "country": "Tuvalu",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/tuvalu/tuvalu-launches-typhoid-campaign",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "yes",
        "https://www.adb.org/sites/default/files/project-documents/50282/50282-001-rrp-en.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://reliefweb.int/report/tuvalu/tuvalu-launches-typhoid-campaign ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/tuvalu/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 182,
  "country": "Uganda",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "No source provided",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://uniph.go.ug/epidemiological-characteristics-and-trend-of-suspected-measles-uganda-2011-2018/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.technet-21.org/en/resources/journal-article/the-role-of-national-immunization-technical-advisory-groups-nitags-in-the-introduction-of-inactivated-polio-vaccine-experience-of-the-indonesia-and-uganda-nitags ",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC5853604/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://library.health.go.ug/sites/default/files/resources/UNEPI%20M&E%20PLAN%2024-28%20final%20Version.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/dff9f6f2ab6a045e85105d55ff202bf49dd9ac17_1.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.nitag-resource.org/resources/uganda-national-immunisation-technical-advisory-group-position-paper-public-health ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.springermedizin.de/comparing-full-immunisation-status-of-children-0-23-months-betwe/25921426 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://zdlh.gavi.org/country-profiles/uganda",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11550497/",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 183,
  "country": "Ukraine",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/news/item/20-02-2024-a-vision-for-health-for-all-by-2030---who-and-the-ukrainian-ministry-of-health-unveil-a-new-country-cooperation-strategy",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/099012325220014406/pdf/P17589519d9d2f0b31a321125b387045f63.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/groups/national-immunization-technical-advisory-groups-(nitags) ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://eurohealthobservatory.who.int/news-room/articles/item/ukraine-country-snapshot-public-health-agencies-and-services-in-the-response-to-covid-19",
        "https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1380627/full",
        "https://health.gov.tt/sites/default/files/2023-09/Revised-Stakeholder-Engagement-Plan-SEP-Republic-of-Trinidad-and-Tobago-COVID-19-EMERGENCY-RESPONSE-PROJECT-P173989.pdf",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://mfa.gov.ua/en/news/nations-against-disinformation-zapusk-novogo-kreativnogo-instrumentu-z-protidiyi-dezinformaciyi ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/ukraine/immunization-bcg-percent-of-one-year-old-children-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 184,
  "country": "United Arab Emirates",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.uaelegislation.gov.ae/en/policy/details/lsy-s-lotny-llthsyn-t-ldol-l-m-r-t-laarby-lmthd",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://documents1.worldbank.org/curated/en/099012325220014406/pdf/P17589519d9d2f0b31a321125b387045f63.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.vaccines4life.com/wp-content/uploads/2021/05/SAAV_Environmental-Scan_United-Arab-Emirates.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.uaelegislation.gov.ae/en/policy/details/lsy-s-lotny-llthsyn-t-ldol-l-m-r-t-laarby-lmthd",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "5"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9376339/ ",
        "https://www.thenationalnews.com/news/uae/2024/09/05/four-in-ten-uae-parents-unsure-about-importance-of-childhood-vaccines-study-shows/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "5"
    }
  ]
}, {
  "id": 185,
  "country": "United Kingdom",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.england.nhs.uk/long-read/nhs-vaccination-strategy/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10604541/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.england.nhs.uk/long-read/delegation-proposals-for-vaccination-and-screening/",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC6143477/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.gov.uk/government/news/latest-childhood-vaccination-uptake-statistics-published ",
        "https://digital.nhs.uk/data-and-information/publications/statistical/nhs-immunisation-statistics/england-2023-24/6in-1-vaccine? OM_6Dd98 ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gov.uk/government/news/ukhsa-publishes-first-annual-report-summarising-latest-infectious-disease-trends",
        "https://www.bmj.com/content/387/bmj-2024-079550",
        "https://bjgpopen.org/content/8/4/BJGPO.2024.0129",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 186,
  "country": "United States",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "No source provided",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "no source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/resources/structure-role-and-procedures-us-advisory-committee-immunization-practices-acip ",
        "https://cdn.who.int/media/docs/librariesprovider2/euro-health-topics/vaccines-and-immunization/tor-template-eng-final_web.pdf?sfvrsn=57b04310_3&download=true ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.hhs.gov/sites/default/files/vaccines-federal-implementation-plan-2021-2025.pdf",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "No source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.cidrap.umn.edu/childhood-vaccines/childhood-vaccine-uptake-continues-decline-while-exemptions-reach-record-high ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.cdc.gov/flu-burden/php/data-vis-vac/2023-2024-prevented.html",
        "https://www.cdc.gov/vaccines/ed/downloads/omnibus-surveys-report-2024-07.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 187,
  "country": "Uruguay",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://sustainabledevelopment.un.org/content/documents/293422021_VNR_Report_Uruguay_English.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.vaccines4life.com/wp-content/uploads/2021/05/NITAGs-Technical-Report-Updated-FINAL.June_.pdf",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/ ",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://en.mercopress.com/2025/03/17/uruguay-s-health-ministry-launches-vax-campaign",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://en.mercopress.com/2025/03/17/uruguay-s-health-ministry-launches-vax-campaign ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://en.mercopress.com/2024/05/24/uruguay-respiratory-diseases-on-the-rise-amid-low-vaccination-coverage ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://en.mercopress.com/2025/03/17/uruguay-s-health-ministry-launches-vax-campaign",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 188,
  "country": "Uzbekistan",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.who.int/europe/news-room/07-09-2022-uzbekistan-achieves-high-hpv-vaccination-coverage-against-cervical-cancer",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/measles-surging-and-uzbekistan-bolstering-its-defences",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://tashkenttimes.uz/national/12870-immunization-in-uzbekistan-is-a-story-of-human-triumph-unicef",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11881447/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/decade-progress-rotavirus-vaccination-transforms-child-health-outcomes-uzbekistan ",
        "https://www.who.int/europe/news-room/07-09-2022-uzbekistan-achieves-high-hpv-vaccination-coverage-against-cervical-cancer ",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.gazeta.uz/en/2024/04/24/immunization/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 189,
  "country": "Vanuatu",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "yes",
        "https://r4d.org/projects/tupaia-and-immunization-coverage-in-vanuatu/",
        "https://investvanuatu.vu/news/covid-19-vaccine-information/",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://respondglobal.com/articles/respond-global-vanuatu-mission-press-release/ ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://tradingeconomics.com/vanuatu/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.adb.org/results/vaccinating-vanuatu-healthier-future",
        "https://tradingeconomics.com/vanuatu/immunization-hib3-percent-of-children-ages-12-23-months-wb-data.html",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 190,
  "country": "Vatican City",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "yes",
        "https://www.ncronline.org/news/vatican/vatican-relaxes-vaccine-mandate-masking-rules",
        "https://www.franciscanmedia.org/news-commentary/vatican-calls-for-equitable-covid-19-vaccine-distribution/",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/sites/default/files/2021-03/2020%20EURO%20training%20Mosina%20et%20al.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.ncregister.com/cna/vatican-to-vaccinate-1-200-people-in-need-during-holy-week ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "4"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.catholicnewsagency.com/news/249975/vatican-tightens-covid-19-rules-for-offices-of-roman-curia ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "4"
    }
  ]
}, {
  "id": 191,
  "country": "Venezuela",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "yes",
        "https://gh.bmj.com/content/9/3/e014464",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "2"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://reliefweb.int/report/venezuela-bolivarian-republic/unicef-venezuela-situation-report-no-1-mid-year-01-january-30-june-2024 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "totalScore": "2"
    }
  ]
}, {
  "id": 192,
  "country": "Vietnam",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "No source provided",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://lawnet.vn/thong-tin-phap-luat/en/chinh-sach-moi/the-ministry-of-health-of-vietnam-to-issue-the-expanded-immunization-plan-for-2025-167274.html",
        "https://en.vietnamplus.vn/measles-vaccination-campaign-expanded-amid-outbreak-risk-post311017.vnp",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://thinkwell.global/wp-content/uploads/2018/09/Vietnam-Country-Brief-081618.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://lawnet.vn/en/laws/target-to-2025-will-vietnam-master-the-technology-to-produce-10-vaccines-produce-at-least-03-vaccin-48043.html",
        "https://lawnet.vn/en/laws/what-is-the-roadmap-to-increase-the-number-of-vaccines-in-the-vietnam-expanded-immunization-program-34307.html",
        "https://vietnamlawmagazine.vn/vietnam-to-master-production-technology-of-10-types-of-human-vaccines-by-2025-37993.html",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC10236357/",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://immunizationeconomics.org/wp-content/uploads/2024/03/5.ICANVietnamEPPPlan_20191112.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.globenewswire.com/news-release/2024/10/31/2972780/28124/en/Vietnam-Human-Vaccines-Import-Research-Report-2024-United-States-France-Belgium-Thailand-Netherlands-India-Analysis-2021-2024-Forecasts-2024-2033.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://assets.kpmg.com/content/dam/kpmg/vn/pdf/publication/2024/10/life-course-immunization-report-en.pdf",
        "https://en.vietnamplus.vn/expanded-programme-on-immunisation-solid-shield-against-epidemics-post296567.vnp",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 193,
  "country": "Yemen",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://reliefweb.int/report/yemen/polio-immunization-campaign-protect-13-million-children-12-governorates-yemen",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://yemen.un.org/en/247113-who-and-unicef-yemen-collaborate-emergency-integrated-measles-and-rubella-vaccination",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "yes",
        "https://reliefweb.int/report/yemen/yemen-ministry-public-health-and-population-gavi-who-and-unicef-launch-oral-cholera-vaccination-campaign-targeting-38-million-people-6-governorates-enar",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://emphnet.net/media/iu2aeecl/gavi_y24_yemen-southern-governorates-pef-tca-project-brief.pdf",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://emphnet.net/media/iu2aeecl/gavi_y24_yemen-southern-governorates-pef-tca-project-brief.pdf ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.emro.who.int/yemen/news/yemen-the-ministry-of-public-health-and-population-gavi-who-and-unicef-launch-an-oral-cholera-vaccination-campaign-targeting-38-million-people-in-6-governorates.html ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.emro.who.int/yemen/priority-areas/expanded-programme-on-immunization.html",
        "https://www.unicef.org/media/139071/file/SOWC23%20MENA%20Brief,%20English.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}, {
  "id": 194,
  "country": "Zambia",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.exemplars.health/topics/vaccine-delivery/zambia/context",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/news/more-6-million-zambian-children-be-vaccinated-against-measles-and-rubella-nationwide",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.medrxiv.org/content/10.1101/2021.11.29.21267021v1.full ",
        "https://www.nitag-resource.org/news/nitag-zambia",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://www.exemplars.health/topics/vaccine-delivery/zambia/how-did-zambia-implement",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/zimnitag-back-track",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://journals.plos.org/globalpublichealth/article?id=10.1371%2Fjournal.pgph.0002820 ",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://journals.plos.org/globalpublichealth/article?id=10.1371%2Fjournal.pgph.0003028 ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.afro.who.int/sites/default/files/2023-08/Zambia.pdf",
        "https://thp.znphi.co.zm/index.php/thehealthpress/issue/download/23/86",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 195,
  "country": "Zimbabwe",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.gavi.org/vaccineswork/routine-immunisation-credited-drop-infant-deaths-zimbabwe",
        "https://www.afro.who.int/countries/zimbabwe/news/zimbabwes-polio-vaccination-campaign-protects-5-million-children",
        "https://www.hararepost.co.zw/en/the-news/local-news/9662-zimbabwe-to-launch-5th-national-polio-vaccination-campaign",
        "https://faolex.fao.org/docs/pdf/zim225019.pdf",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.impactpool.org/jobs/717185",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "Yes",
        "https://www.fondation-merieux.org/wp-content/uploads/2023/06/introducing-pcv-rotavirus-vaccine-2023-day-2-joseph-biey.pdf ",
        "https://health.uct.ac.za/sites/default/files/content_migration/health_uct_ac_za/1457/files/AAVC%25202015-%2520NITAGs%2520Final.pdf",
        "",
        "",
        "1"
      ],
      "answers2": [
        "yes",
        "https://documents1.worldbank.org/curated/en/099091924053030057/pdf/P17614114fba550ce1a1e915543c748c33b.pdf",
        "https://www.afro.who.int/fr/node/20102",
        "https://www.poliokit.org/news/strategic-social-and-behavior-change-initiatives-zimbabwes-polio-vaccination-efforts",
        "https://www.gavi.org/vaccineswork/tracking-routine-immunisation-rural-zimbabwe",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.nitag-resource.org/news/zimnitag-back-track",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.poliokit.org/news/overcoming-misinformation-and-engaging-communities-zimbabwes-polio-vaccination-campaign-0 ",
        "https://www.nitag-resource.org/news/nitag-recommendations-related-covid-19-pandemic-situation ",
        "https://www.nitag-resource.org/news/new-members-zimbabwe-nitag ",
        "",
        "1"
      ],
      "totalScore": "8"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://www.gavi.org/vaccineswork/outbreak-hit-zimbabweans-embrace-cholera-vaccines-open-arms ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://www.gavi.org/vaccineswork/routine-immunisation-credited-drop-infant-deaths-zimbabwe",
        "https://www.unicef.org/media/169301/file/UNICEF%20Zimbabwe%20Humanitarian%20Situation%20Report%20No.%201,%20Jan%20-%20Feb%202025.pdf.pdf",
        "",
        "",
        "1"
      ],
      "totalScore": "8"
    }
  ]
}, {
  "id": 196,
  "country": "Palestine",
  "questions": [
    {
      "no": 1,
      "question": "1) Are there any vaccination goals and targets?",
      "q1": "a. There are goals for future vaccine needs(e.g., over the next 3, 5 or 10 years)",
      "q2": "b. There is more than specific, officially published and well-known national vaccination target to be researched by a specific date (e.g., measles elimination by end 2025).",
      "answers1": [
        "Yes",
        "https://www.ifrc.org/press-release/gavi-ifrc-and-unicef-collaborate-emergency-response-palestine-0",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://english.wafa.ps/Pages/Details/154902",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 2,
      "question": "2) Is there a national vaccination plan?",
      "q1": "a. There is one (and only one) plan published by a WHO-type NITAG",
      "q2": "b. Pipeline vaccines are continuously reviewed pre-licensure by NITAG.",
      "answers1": [
        "No",
        "",
        "",
        "",
        "",
        "0"
      ],
      "answers2": [
        "Yes",
        "https://www.hrw.org/news/2021/03/19/israels-discriminatory-vaccine-push-underscores-need-action",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC9790952/",
        "https://www.map.org.uk/downloads/map-position-paper---equal-access-to-covid-19-vaccines-.pdf",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 3,
      "question": "3) Is there appropriate implementation of the NITAG plan?",
      "q1": "a. There are clearly defined responsibilities and accountabilities for implementation of the NITAG plan with action in case of failure.",
      "q2": "b. The NITAG plan is regularly supported by government-funded national information campaigns.",
      "answers1": [
        "Yes",
        "https://www.meig.ch/highlight-12-implementation-monitoring-accountability-and-review-of-sdg-16-peace-justice-and-strong-institutions-in-the-case-of-palestine-and-ghana/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "No Source",
        "",
        "",
        "",
        "1"
      ],
      "totalScore": "7"
    },
    {
      "no": 4,
      "question": "4) Is there a scientifically valid evaluation of implementation success?",
      "q1": "a. There are up to date (less than every 2 years) validated studies on vaccine-uptake, completion and compliance at age 2 years, before shool entry, for adolescents and for those more than 65 years(some countires: more than 60 years).",
      "q2": "b. There is scientifically sound and timely (less than 2 years) burden-of-diseases data by age group on all vaccine-preventable diseases including relevant pipelione vaccines.",
      "answers1": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC8949838/ ",
        "",
        "",
        "",
        "1"
      ],
      "answers2": [
        "Yes",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC11919384/ ",
        "https://www.palestine-studies.org/en/node/1656195 ",
        "https://clinmedjournals.org/articles/jide/journal-of-infectious-diseases-and-epidemiology-jide-10-328.php ",
        "",
        "1"
      ],
      "totalScore": "7"
    }
  ]
}
] 